A Comparative Study of Glial and Non-neural Cell Properties for Transplant-Mediated Repair of the Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord Group , Institute of Neuroscience & Psychology , College of Medical , Veterinary and Life Sciences , University of Glasgow , Glasgow , G12 8QQ , United Kingdom 2Glial Cell Biology Group , Institute of Infection , Immunity and Inflammation , College of Medical , Veterinary and Life Sciences , University of Glasgow , Glasgow , G12 8TA , United Kingdom ABSTRACT Cell transplantation is one strategy for encouraging regeneration after spinal cord injury and a range of cell types have been investigated for their repair potential .	1
A Comparative Study	1
Glial and Non-neural Cell Properties for Transplant-Mediated Repair of the Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord	24
Glial	24
Non-neural Cell Properties for Transplant-Mediated Repair of the Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord	34
Non-neural Cell Properties	34
Transplant-Mediated Repair of the Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord	65
Transplant-Mediated Repair	65
the Injured Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord	95
the	95
Spinal Cord ANDREW TOFT ,1,2 * MERCEDES TOME ,1,2 SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord	107
Spinal Cord ANDREW TOFT ,1,2	107
Spinal Cord ANDREW TOFT	107
,1,2	131
MERCEDES TOME ,1,2	137
MERCEDES TOME	137
,1,2	150
SUSAN C. BARNETT ,2 AND JOHN S. RIDDELL1 1Spinal Cord	155
SUSAN C. BARNETT	155
,2 AND JOHN S. RIDDELL1 1Spinal Cord	171
,2	171
JOHN S. RIDDELL1 1Spinal Cord	178
Institute of Neuroscience & Psychology	215
Institute	215
Neuroscience & Psychology	228
College of Medical	255
College	255
Medical	266
Veterinary and Life Sciences	275
Veterinary	275
Life Sciences	290
University of Glasgow	305
University	305
Glasgow	319
Glasgow	328
G12 8QQ	337
United Kingdom 2Glial Cell Biology Group	346
Institute of Infection , Immunity and Inflammation	388
Institute	388
Infection , Immunity and Inflammation	401
College of Medical	439
College	439
Medical	450
Veterinary and Life Sciences	459
Veterinary	459
Life Sciences	474
University of Glasgow	489
University	489
Glasgow	503
Glasgow	512
G12 8TA	521
United Kingdom ABSTRACT Cell transplantation	530
one strategy for encouraging regeneration after spinal cord injury	579
one strategy	579
encouraging regeneration after spinal cord injury	596
encouraging regeneration	596
spinal cord injury	627
a range of cell types	650
a range	650
cell types	661
their repair potential	699
variations in study design	732
variations	732
study design	746
determination of which cells are most effective	770
determination	770
cells	793
this study	822
we	833
a direct comparison of the regenerative and integrative properties of several cell preparations following transplantation into the lesioned rat spinal cord	853
a direct comparison	853
the regenerative and integrative properties of several cell preparations following transplantation into the lesioned rat spinal cord	876
the regenerative and integrative properties	876
several cell preparations following transplantation into the lesioned rat spinal cord	923
several cell preparations	923
transplantation into the lesioned rat spinal cord	959
transplantation	959
the lesioned rat spinal cord	980
Transplants	1010
olfactory ensheathing cells -LRB- OECs -RRB- and -LRB- ii -RRB- fibroblast-like cells , from olfactory bulb -LRB- OBFB-L -RRB- , -LRB- iii -RRB-	1045
olfactory ensheathing cells -LRB- OECs -RRB- and -LRB- ii -RRB- fibroblast-like cells , from olfactory bulb -LRB- OBFB-L -RRB- ,	1045
olfactory ensheathing cells -LRB- OECs -RRB- and -LRB- ii -RRB- fibroblast-like cells	1045
olfactory ensheathing cells -LRB- OECs -RRB-	1045
olfactory ensheathing cells	1045
OECs	1074
ii	1085
fibroblast-like cells	1089
olfactory bulb -LRB- OBFB-L -RRB-	1117
olfactory bulb	1117
OBFB-L	1133
iii	1143
a 50:50 mixture of -LRB- i -RRB- and -LRB- ii -RRB- -LRB- OEC/OBFB-L -RRB- , -LRB- iv -RRB- dissociated nasal mucosa -LRB- OM -RRB- , -LRB- v -RRB- purified peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB- peripheral nerve fibroblasts , and -LRB- vii -RRB- skin fibroblasts -LRB- SF -RRB-	1148
a 50:50 mixture of -LRB- i -RRB- and -LRB- ii -RRB- -LRB- OEC/OBFB-L -RRB- , -LRB- iv -RRB- dissociated nasal mucosa -LRB- OM -RRB- , -LRB- v -RRB- purified peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB- peripheral nerve fibroblasts , and -LRB- vii -RRB- skin fibroblasts	1148
a 50:50 mixture of -LRB- i -RRB- and -LRB- ii -RRB- -LRB- OEC/OBFB-L -RRB- , -LRB- iv -RRB-	1148
a 50:50 mixture	1148
-LRB- i -RRB- and -LRB- ii -RRB- -LRB- OEC/OBFB-L -RRB-	1167
-LRB- i -RRB-	1167
ii	1176
-LRB- OEC/OBFB-L -RRB-	1180
iv	1195
nasal mucosa -LRB- OM -RRB- , -LRB- v -RRB- purified peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB- peripheral nerve fibroblasts , and -LRB- vii -RRB- skin fibroblasts	1211
nasal mucosa -LRB- OM -RRB- , -LRB- v -RRB- purified peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB- peripheral nerve fibroblasts	1211
nasal mucosa -LRB- OM -RRB- , -LRB- v -RRB-	1211
nasal mucosa -LRB- OM -RRB-	1211
nasal mucosa	1211
OM	1225
v	1231
peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB- peripheral nerve fibroblasts	1243
peripheral nerve Schwann cells -LRB- SCs -RRB- , -LRB- vi -RRB-	1243
peripheral nerve Schwann cells -LRB- SCs -RRB-	1243
peripheral nerve Schwann cells	1243
SCs	1275
vi	1282
peripheral nerve fibroblasts	1286
vii	1321
skin fibroblasts	1326
SF	1344
All transplants	1349
axonal regeneration	1375
OECs and SCs	1396
the greatest regeneration while OBFB-like cells were least efficient and mixed cell populations	1418
the greatest regeneration	1418
OBFB-like cells	1450
least efficient and mixed cell populations	1471
purified populations	1539
Tract-tracing experiments	1561
none of the cell types	1605
none	1605
the cell types	1613
regeneration	1637
the lesion	1657
all cell types	1678
cavity formation	1703
the extent of astrocytic hypertrophy	1721
the extent	1721
astrocytic hypertrophy	1735
GFAP immunoreactivity -LRB- IR -RRB-	1759
GFAP immunoreactivity	1759
IR	1782
the transplant/lesion site -RSB- differed markedly	1789
the transplant/lesion site	1789
OECs and SCs	1836
the least GFAP-IR	1870
fibroblasts and fibroblast-like cells	1889
fibroblasts	1889
fibroblast-like cells	1905
greater GFAP-IR	1939
hypertrophy surrounding transplants of OM	1961
hypertrophy	1961
transplants of OM	1985
transplants	1985
OM	2000
These differences in host-transplant reactivity	2023
These differences	2023
host-transplant reactivity	2044
cells	2103
normal spinal cord	2114
the cellular interaction	2139
injury	2186
purified glial cells	2200
advantages for transplant-mediated repair	2226
advantages	2226
transplant-mediated repair	2241
maximal support	2279
axonal regeneration	2299
a minimal astrocytic reaction around the transplant site	2324
a minimal astrocytic reaction	2324
the transplant site	2361
INTRODUCTION Spinal cord injury	2383
INTRODUCTION	2383
Spinal cord injury	2396
the loss of conduction in axonal pathways	2426
the loss	2426
conduction in axonal pathways	2438
conduction	2438
axonal pathways	2452
the spinal cord	2493
This	2510
permanent deficits of sensory , motor , and autonomic function	2524
permanent deficits	2524
sensory , motor , and autonomic function	2546
sensory	2546
motor	2555
autonomic function	2566
these axonal pathways	2608
The failure of axonal regeneration within the CNS	2649
The failure	2649
axonal regeneration within the CNS	2664
axonal regeneration	2664
the CNS	2691
the presence of inhibitory signals and absence of stimulatory signals in the lesion environment	2730
the presence of inhibitory signals	2730
the presence	2730
inhibitory signals	2746
absence of stimulatory signals in the lesion environment	2769
absence	2769
stimulatory signals in the lesion environment	2780
stimulatory signals	2780
the lesion environment	2803
Fawcett , 2006 ; Fitch and Silver , 2008 ; Hollis and Tuszynski , 2011	2827
Fawcett	2827
2006 ; Fitch and Silver , 2008 ; Hollis and Tuszynski	2836
2006	2836
Fitch and Silver , 2008 ; Hollis and Tuszynski	2842
Fitch and Silver	2842
2008	2860
Hollis	2866
Tuszynski	2877
2011	2888
The use of cell transplants for promoting axonal regeneration and spinal cord repair	2895
The use	2895
cell transplants for promoting axonal regeneration and spinal cord repair	2906
cell transplants	2906
axonal regeneration and spinal cord repair	2937
axonal regeneration	2937
spinal cord repair	2961
an active area of investigation for several decades	2989
an active area	2989
investigation for several decades	3007
investigation	3007
several decades	3025
recent advances in glial and stem cell biology resulting in a proliferation of cell types with the potential to mediate repair	3046
recent advances in glial	3046
recent advances	3046
stem cell biology resulting in a proliferation of cell types with the potential to mediate repair	3075
stem cell biology	3075
a proliferation of cell types with the potential	3106
a proliferation	3106
cell types with the potential	3125
cell types	3125
the potential	3141
repair	3166
Investigations	3174
stem cells of varying origins -LRB- Louro and Pearse , 2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al. , 2011 -RRB- , cells from the peripheral nervous system -LSB- e.g. , Schwann cells -LRB- SCs -RRB- -RSB- where axonal regeneration successfully occurs and specialized glial cells found in the olfactory system where sensory neurons regenerate throughout life -LRB- Raisman and Li 2007 ; Barnett and Riddell 2007 -RRB-	3213
stem cells	3213
varying origins -LRB- Louro and Pearse , 2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al. , 2011 -RRB- , cells from the peripheral nervous system -LSB- e.g. , Schwann cells -LRB- SCs -RRB- -RSB- where axonal regeneration successfully occurs and specialized glial cells found in the olfactory system where sensory neurons regenerate throughout life -LRB- Raisman and Li 2007 ; Barnett and Riddell 2007 -RRB-	3227
varying origins -LRB- Louro and Pearse , 2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al. , 2011 -RRB-	3227
varying origins	3227
Louro and Pearse , 2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al. , 2011	3244
Louro and Pearse	3244
2008 ; Nandoe Tewarie et al. , 2010 ; Tetzlaff et al.	3262
2008	3262
Nandoe Tewarie et al. , 2010 ; Tetzlaff et al.	3268
Nandoe Tewarie	3268
et al. , 2010 ; Tetzlaff et al.	3283
et al. , 2010	3283
et al.	3283
2010	3291
Tetzlaff et al.	3297
Tetzlaff	3297
et al.	3306
2011	3314
cells from the peripheral nervous system -LSB- e.g.	3321
cells	3321
the peripheral nervous system -LSB- e.g.	3332
the peripheral nervous system	3332
e.g.	3363
Schwann cells -LRB- SCs -RRB- -RSB- where axonal regeneration successfully occurs	3369
Schwann cells	3369
SCs	3384
specialized glial cells found in the olfactory system where sensory neurons regenerate throughout life -LRB- Raisman and Li 2007 ; Barnett and Riddell 2007 -RRB-	3440
specialized glial cells found in the olfactory system where sensory neurons regenerate throughout life	3440
specialized glial cells	3440
the olfactory system where sensory neurons regenerate throughout life	3473
the olfactory system	3473
sensory neurons	3500
life	3538
Raisman and Li 2007 ; Barnett and Riddell 2007	3544
Raisman and Li 2007 ; Barnett and Riddell	3544
Raisman and Li 2007	3544
Raisman	3544
Li 2007	3556
Barnett and Riddell	3565
Barnett	3565
Riddell	3577
2007	3585
Fibroblasts obtained from various tissues	3592
Fibroblasts	3592
various tissues	3618
a cell scaffold for supporting axonal regeneration in combination with other therapies -LRB- e.g. , neurotrophins , Grill et al. , 1997 ; Lu and Tuszynski , 2008 -RRB- rather than because	3681
a cell scaffold	3681
axonal regeneration	3712
combination with other therapies -LRB- e.g. , neurotrophins , Grill et al. , 1997 ; Lu and Tuszynski , 2008 -RRB-	3735
combination	3735
other therapies -LRB- e.g. , neurotrophins , Grill et al. , 1997 ; Lu and Tuszynski , 2008 -RRB-	3752
other therapies	3752
e.g. , neurotrophins , Grill et al. , 1997 ; Lu and Tuszynski , 2008	3769
e.g. , neurotrophins	3769
e.g.	3769
neurotrophins	3775
Grill et al.	3790
Grill	3790
et al.	3796
1997 ; Lu and Tuszynski , 2008	3804
1997	3804
Lu and Tuszynski , 2008	3810
Lu and Tuszynski	3810
2008	3828
they	3854
any identified intrinsic growth promoting properties	3864
any identified intrinsic growth	3864
properties	3906
there	3927
general agreement	3936
several cell types	3959
axonal regeneration	4004
the transplant environment	4031
some degree	4061
there	4074
varying and even contradictory reports of the extent of their repair potential	4084
varying	4084
even contradictory reports of the extent of their repair potential	4096
even contradictory reports	4096
the extent of their repair potential	4126
the extent	4126
their repair potential	4140
it	4167
cell type	4189
the best support for axonal regeneration	4208
the best support	4208
axonal regeneration	4229
A problem in making any such comparison	4250
A problem	4250
any such comparison	4270
the wide variation in study designs employed	4293
the wide variation	4293
study designs employed	4315
study designs	4315
Different lesion models	4339
regeneration of different systems of spinal cord fibers	4382
regeneration	4382
different systems of spinal cord fibers	4398
different systems	4398
spinal cord fibers	4419
Few studies	4457
the extent of regeneration of these different cell transplants	4492
the extent	4492
regeneration of these different cell transplants	4506
regeneration	4506
these different cell transplants	4522
the same experimental conditions	4561
The first aim of this study	4595
The first aim	4595
this study	4612
the ability of several candidate cell types	4648
the ability	4648
several candidate cell types	4663
axonal regeneration following spinal cord lesions to determine whether one cell type has a greater potential than another	4703
axonal regeneration	4703
spinal cord lesions to determine whether one cell type has a greater potential than another	4733
one cell type	4774
a greater potential than another	4792
a greater potential	4792
another	4817
The comparison	4826
cells that would be suitable for autologous transplantation	4870
cells	4870
autologous transplantation	4903
some reports	4934
mixtures of cells	4967
mixtures	4967
cells	4979
an advantage -LRB- Li et al. , 2005a -RRB-	4994
an advantage	4994
Li	5008
et al. , 2005a	5011
et al.	5011
2005a	5019
some cases	5033
transplantation of complete tissues -LRB- e.g. , olfactory mucosa , Lu et al. , 2001 -RRB-	5045
transplantation	5045
complete tissues -LRB- e.g. , olfactory mucosa , Lu et al. , 2001 -RRB-	5064
complete tissues	5064
e.g. , olfactory mucosa	5082
e.g.	5082
olfactory mucosa	5088
Lu et al. , 2001	5106
Lu	5106
et al.	5109
2001	5117
we	5143
our choice of cells , non-neural cells which may contaminate glial cell preparations , cells which have been included together with glial cells in mixed cell transplants and cells which would be contained in tissue transplants	5158
our choice of cells , non-neural cells which may contaminate glial cell preparations	5158
our choice	5158
cells , non-neural cells which may contaminate glial cell preparations	5172
cells	5172
non-neural cells which may contaminate glial cell preparations	5179
non-neural cells	5179
glial cell preparations	5218
cells which have been included together with glial cells in mixed cell transplants	5243
cells	5243
glial cells in mixed cell transplants	5288
glial cells	5288
mixed cell transplants	5303
cells which would be contained in tissue transplants	5330
cells	5330
tissue transplants	5364
some cases	5387
mixtures of glial and non-neural cells	5399
mixtures	5399
glial and non-neural cells	5411
axonal regeneration	5472
candidate cells for transplant	5493
candidate cells	5493
transplant	5513
CNS repair	5533
the host spinal cord	5581
endogenous glial cells	5624
the glial scar	5673
there	5698
evidence that olfactory ensheathing cells -LRB- OECs -RRB- interact more favorably with astrocytes than SCs , both in vitro and when transplanted into spinal cord tissue -LRB- Ghirnikar and Eng , 1994 ; Lakatos et al. , 2000 ; Santos-Silva et al. , 2007 -RRB-	5707
evidence	5707
olfactory ensheathing cells -LRB- OECs -RRB-	5721
olfactory ensheathing cells	5721
OECs	5750
astrocytes than SCs	5785
astrocytes	5785
SCs	5801
spinal cord tissue -LRB- Ghirnikar and Eng , 1994 ; Lakatos et al. , 2000 ; Santos-Silva et al. , 2007 -RRB-	5847
spinal cord tissue	5847
Ghirnikar and Eng , 1994 ; Lakatos et al. , 2000 ; Santos-Silva et al. , 2007	5867
Ghirnikar and Eng	5867
1994 ; Lakatos et al. , 2000 ; Santos-Silva et al.	5886
1994	5886
Lakatos et al. , 2000 ; Santos-Silva et al.	5892
Lakatos	5892
et al. , 2000 ; Santos-Silva et al.	5900
et al. , 2000	5900
et al.	5900
2000	5908
Santos-Silva et al.	5914
Santos-Silva	5914
et al.	5927
2007	5935
little	5942
other candidate cell types	5964
A further aim of this study	5992
A further aim	5992
this study	6009
different candidates for cell transplantation	6052
different candidates	6052
cell transplantation	6077
the host spinal cord	6113
others	6154
Our study	6162
a diverse range of cell types	6183
a diverse range	6183
cell types	6202
substantial axonal regeneration	6239
none of those tested	6279
none	6279
those tested	6287
those	6287
regeneration	6308
the lesion	6328
we	6364
certain cell types	6382
marked astrocytosis	6408
the host spinal cord at the transplant site	6431
the host spinal cord	6431
the transplant site	6455
This	6476
cells that are potential contaminants of glial cell populations	6490
cells	6490
potential contaminants of glial cell populations	6505
potential contaminants	6505
glial cell populations	6531
Selection of the optimum cells for transplant	6555
Selection	6555
the optimum cells for transplant	6568
the optimum cells	6568
transplant	6590
repair of spinal cord injuries	6610
repair	6610
spinal cord injuries	6620
account not only the regenerative properties of candidate cells but also their ability to integrate favorably within the host neuropil	6668
account	6668
the regenerative properties of candidate cells but also their ability to integrate favorably within the host neuropil	6685
the regenerative properties of candidate cells	6685
the regenerative properties	6685
candidate cells	6716
their ability to integrate favorably within the host neuropil	6741
the host neuropil	6785
MATERIALS AND METHODS Animals Fisher 344 rats -LRB- Harlan , Loughborough , UK -RRB-	6804
MATERIALS AND METHODS Animals Fisher 344 rats	6804
MATERIALS	6804
METHODS Animals Fisher 344 rats	6818
METHODS Animals	6818
Fisher 344 rats	6834
Harlan	6851
Loughborough	6859
UK	6873
both cell preparation and transplantation	6891
both cell preparation	6891
transplantation	6917
Olfactory mucosa , olfactory bulbs and sciatic nerves	6934
Olfactory mucosa	6934
olfactory bulbs	6952
sciatic nerves	6972
postnatal day 7 -LRB- P7 -RRB- rats	7006
day 7	7016
P7	7023
transplants	7038
syngeneic adult male animals -LRB- 200 -- 250 g -RRB-	7068
syngeneic adult male animals	7068
200 -- 250 g	7098
200	7098
250 g	7102
All experimental procedures	7110
the Ethical Review Panel of the University of Glasgow	7155
the Ethical Review Panel	7155
the University of Glasgow	7183
the University	7183
Glasgow	7201
accordance with the UK Animals -LRB- Scientific Procedures -RRB-	7226
accordance	7226
the UK Animals -LRB- Scientific Procedures -RRB-	7242
the UK Animals	7242
Scientific Procedures	7258
Act 1986	7281
Cell Cultures Primary olfactory mucosal cell culture Olfactory mucosal cells	7291
Cell Cultures	7291
Primary olfactory mucosal cell culture Olfactory mucosal cells	7305
Tome	7409
et al. -LRB- 2009 -RRB-	7414
et al.	7414
2009	7422
olfactory bulbs	7438
the heads of postnatal day 7 -LRB- P7 -RRB- rats	7472
the heads	7472
postnatal day 7 -LRB- P7 -RRB- rats	7485
day 7	7495
P7	7502
The head	7512
each turbinate	7548
forceps	7578
cold Hank 's balanced salt solution -LRB- HBSS , Invitrogen , Paisley , UL -RRB-	7600
cold Hank 's balanced salt solution	7600
cold Hank 's	7600
HBSS	7636
Invitrogen	7642
Paisley , UL	7654
The olfactory mucosa	7668
the turbinate with forceps	7708
the turbinate	7708
forceps	7727
the microscope	7741
a scalpel	7784
The tissue obtained from 7 to 9 animals	7795
The tissue	7795
7 to 9 animals	7820
1.33 % collagenase -LRB- Sigma , Dorset , UK -RRB-	7861
1.33 % collagenase	7861
Sigma	7880
Dorset	7887
UK	7895
37 C in a 7 % CO2 incubator for 20 min	7902
37 C	7902
a 7 % CO2 incubator for 20 min	7910
a 7 % CO2 incubator	7910
20 min	7933
Soybean trypsin inhibitor and DNAse	7957
SD , 0.52 mg/mL soybean trypsin inhibitor , 0.04 mg/mL bovine pancreas DNAse , 3.0 mg/mL bovine serum albumin-fraction A	7994
SD , 0.52 mg/mL soybean trypsin inhibitor	7994
SD	7994
0.52 mg/mL soybean trypsin inhibitor	7998
0.52 mg/mL	7998
soybean trypsin inhibitor	8009
0.04 mg/mL bovine pancreas DNAse	8036
0.04 mg/mL	8036
bovine pancreas DNAse	8047
3.0 mg/mL bovine serum albumin-fraction A	8070
3.0 mg/mL	8070
bovine serum albumin-fraction A	8080
L15 , Sigma	8115
L15	8115
Sigma	8120
cell clumping	8137
The cells	8152
several times	8199
a 10 µg/cm2 collagen-coated T25 flask -LRB- Greiner Bio-one -RRB-	8227
a 10 µg/cm2 collagen-coated T25 flask	8227
10 µg/cm2	8229
Greiner Bio-one	8266
DMEM/F12 -LRB- 1:1 , Invitrogen -RRB- supplemented with EGF -LRB- 20 ng/mL , mouse epidermal growth factor , R&D systems , Abingdon , UK -RRB- , FGF2 -LRB- 50 ng/mL Peprotech , London UK -RRB- and LIF -LRB- 103 units/mL , leukemia inhibitory factor , Chemicon International -RRB- for 8 -- 10 days before transplantation	8288
DMEM/F12 -LRB- 1:1 , Invitrogen -RRB- supplemented with EGF -LRB- 20 ng/mL , mouse epidermal growth factor , R&D systems , Abingdon , UK -RRB- , FGF2 -LRB- 50 ng/mL Peprotech , London UK -RRB- and LIF -LRB- 103 units/mL , leukemia inhibitory factor , Chemicon International -RRB- for 8	8288
DMEM/F12 -LRB- 1:1 , Invitrogen -RRB-	8288
DMEM/F12	8288
1:1	8298
Invitrogen	8303
EGF -LRB- 20 ng/mL , mouse epidermal growth factor , R&D systems , Abingdon , UK -RRB- , FGF2 -LRB- 50 ng/mL Peprotech , London UK -RRB- and LIF -LRB- 103 units/mL , leukemia inhibitory factor , Chemicon International -RRB-	8333
EGF -LRB- 20 ng/mL , mouse epidermal growth factor , R&D systems , Abingdon , UK -RRB-	8333
EGF	8333
20 ng/mL , mouse epidermal growth factor , R&D systems , Abingdon , UK	8338
20 ng/mL , mouse epidermal growth factor , R&D systems	8338
Abingdon , UK	8392
FGF2 -LRB- 50 ng/mL Peprotech , London UK -RRB-	8407
FGF2	8407
50 ng/mL Peprotech , London UK	8413
50 ng/mL Peprotech	8413
London UK	8433
LIF -LRB- 103 units/mL , leukemia inhibitory factor , Chemicon International -RRB-	8448
LIF	8448
103 units/mL , leukemia inhibitory factor , Chemicon International	8453
103 units/mL	8453
leukemia inhibitory factor	8467
Chemicon International	8495
8	8523
10 days before transplantation	8525
10 days	8525
transplantation	8540
The cultures	8557
37 °C in a 7 % CO2 incubator	8589
37 °C	8589
a 7 % CO2 incubator	8597
the medium	8620
every 2 -- 3 days	8643
every 2	8643
3 days	8651
OECs and SCs	8668
OECs and SCs	8681
P7 rat pups -LRB- Lakatos et al. , 2000 -RRB-	8737
P7 rat pups	8737
Lakatos	8750
et al. , 2000	8758
et al.	8758
2000	8766
PLL-coated flasks -LRB- 13.3 µg/mL ; Sigma -RRB-	8790
PLL-coated flasks	8790
13.3 µg/mL ; Sigma	8809
13.3 µg/mL	8809
Sigma	8821
FACS purified OECs -LRB- Franceschini and Barnett 1996 -RRB-	8829
FACS	8829
OECs	8843
Franceschini and Barnett 1996	8849
Franceschini	8849
Barnett 1996	8866
DMEM-BS -LRB- serum-free modified DMEM , Bottenstein et al. , 1979 ; Barnett et al. , 1993 -RRB- with 5 % FBS	8897
DMEM-BS -LRB- serum-free modified DMEM , Bottenstein et al. , 1979 ; Barnett et al. , 1993 -RRB-	8897
DMEM-BS	8897
serum-free modified DMEM , Bottenstein et al. , 1979 ; Barnett et al. , 1993	8906
serum-free	8906
DMEM , Bottenstein et al. , 1979 ; Barnett et al. , 1993	8926
DMEM , Bottenstein et al.	8926
DMEM , Bottenstein	8926
et al.	8944
1979	8952
Barnett et al. , 1993	8958
Barnett	8958
et al. , 1993	8966
et al.	8966
1993	8974
5 % FBS	8985
fibroblast growth factor2 -LRB- FGF2 , 500 ng/mL ; Peprotech -RRB- , Hrgb1 -LRB- 50 ng/mL R&D Systems , Abingdon , UK -RRB- , forskolin -LRB- 5 3 1027 M , Sigma -RRB- and astrocyte conditioned medium -LRB- Noble and Murray , 1984 -RRB- which has been shown to be a potent mitogen for promoting prolonged growth of p75 neurotrophin receptor -LRB- p75NTR -RRB- expressing OECs -LRB- Alexander et al. , 2002 -RRB-	9023
fibroblast growth factor2 -LRB- FGF2 , 500 ng/mL ; Peprotech -RRB- , Hrgb1 -LRB- 50 ng/mL R&D Systems , Abingdon , UK -RRB- , forskolin -LRB- 5 3 1027 M , Sigma -RRB- and astrocyte conditioned medium -LRB- Noble and Murray , 1984 -RRB-	9023
fibroblast growth factor2 -LRB- FGF2 , 500 ng/mL ; Peprotech -RRB-	9023
fibroblast growth factor2	9023
FGF2 , 500 ng/mL ; Peprotech	9050
FGF2	9050
500 ng/mL ; Peprotech	9056
500 ng/mL	9056
Peprotech	9067
Hrgb1 -LRB- 50 ng/mL R&D Systems , Abingdon , UK -RRB-	9079
Hrgb1	9079
50 ng/mL R&D Systems , Abingdon , UK	9086
50 ng/mL	9086
R&D Systems	9095
Abingdon , UK	9108
forskolin -LRB- 5 3 1027 M , Sigma -RRB-	9123
forskolin	9123
5 3 1027 M , Sigma	9134
5 3	9134
1027 M	9138
Sigma	9146
astrocyte conditioned medium -LRB- Noble and Murray , 1984 -RRB-	9157
astrocyte conditioned medium	9157
Noble and Murray	9187
1984	9205
a potent mitogen for promoting prolonged growth of p75 neurotrophin receptor -LRB- p75NTR -RRB- expressing OECs -LRB- Alexander et al. , 2002 -RRB-	9238
a potent mitogen	9238
prolonged growth of p75 neurotrophin receptor	9269
prolonged growth	9269
p75 neurotrophin receptor	9289
p75NTR	9316
OECs -LRB- Alexander et al. , 2002 -RRB-	9335
OECs	9335
Alexander	9341
et al. , 2002	9351
et al.	9351
2002	9359
SCs	9366
DMEM-FBS containing forskolin -LRB- 1026 M -RRB- and heregulin beta-1 -LRB- Hrgb1 , 20 ng/mL ; R&D Systems -RRB-	9389
DMEM-FBS	9389
forskolin -LRB- 1026 M -RRB- and heregulin beta-1 -LRB- Hrgb1 , 20 ng/mL ; R&D Systems -RRB-	9409
forskolin -LRB- 1026 M -RRB-	9409
forskolin	9409
1026 M	9420
heregulin beta-1 -LRB- Hrgb1 , 20 ng/mL ; R&D Systems -RRB-	9432
heregulin beta-1	9432
Hrgb1 , 20 ng/mL ; R&D Systems	9450
Hrgb1	9450
20 ng/mL ; R&D Systems	9457
20 ng/mL	9457
R&D Systems	9467
Fibroblast-like cells from olfactory bulbs Fibroblast-like cells were obtained from olfactory bulbs of P7 rats using methods based on those	9481
Fibroblast-like cells	9481
olfactory bulbs Fibroblast-like cells were obtained from olfactory bulbs of P7 rats using methods based on those	9508
olfactory bulbs	9508
Fibroblast-like cells	9524
olfactory bulbs of P7 rats	9565
olfactory bulbs	9565
P7 rats	9584
methods	9598
those	9615
Li	9629
et al. -LRB- 2003 -RRB-	9632
et al.	9632
2003	9640
The olfactory bulbs	9647
the preparation of cell suspension	9729
the preparation	9729
cell suspension	9748
purified OECs	9768
dissociation and treatment with SD	9789
dissociation and treatment	9789
SD	9821
the cells	9824
12,000 rpm	9854
25 cm3 tissue culture flasks containing DMEM-FBS	9881
25 cm3 tissue culture flasks	9881
DMEM-FBS	9921
Cells	9931
three times a week	9946
three times	9946
a week	9958
time , usually 3 -- 4 weeks	9999
time	9999
3	10013
4 weeks	10015
fibroblast-like cells	10023
the major cell type in the cultures	10054
the major cell type	10054
the cultures	10077
lack of p75NTR expression and expression of thy1 .1	10105
lack	10105
p75NTR expression and expression	10113
thy1 .1	10149
muscle actin -LRB- SMA -RRB- -LRB- Fig. 1 -RRB-	10167
muscle actin -LRB- SMA -RRB-	10167
muscle actin	10167
SMA	10181
Fig. 1	10187
Peripheral nerve fibroblasts Peripheral nerve fibroblast -LRB- PNFB -RRB-	10196
Peripheral nerve fibroblasts Peripheral nerve fibroblast	10196
Peripheral nerve fibroblasts	10196
Peripheral nerve fibroblast	10225
PNFB	10254
a similar method	10277
that described by Keyvan-Fouladi et al -LRB- 2003 , 2005 -RRB-	10297
that	10297
Keyvan-Fouladi	10315
et al -LRB- 2003 , 2005 -RRB-	10330
et al	10330
2003	10337
2005	10343
The initial stages of this process	10350
The initial stages	10350
this process	10372
the preparation of SCs from peripheral nerve , but whereas fibroblasts are removed from the SC cultures	10400
the preparation	10400
SCs from peripheral nerve , but whereas fibroblasts are removed from the SC cultures	10419
SCs	10419
peripheral nerve , but whereas fibroblasts are removed from the SC cultures	10428
peripheral nerve	10428
fibroblasts	10458
the SC	10487
they	10509
The sciatic nerves of P7 rats	10540
The sciatic nerves	10540
P7 rats	10562
collagenase -LRB- 1.33 % -RRB-	10606
collagenase	10606
1.33 %	10619
15 min followed by trypsin -LRB- 0.25 % Sigma -RRB- for 15 min	10630
15 min	10630
trypsin -LRB- 0.25 % Sigma -RRB- for 15 min	10649
trypsin -LRB- 0.25 % Sigma -RRB-	10649
trypsin	10649
0.25 % Sigma	10658
0.25 %	10658
Sigma	10664
15 min	10675
dissociation and treatment with SD	10689
dissociation and treatment	10689
SD	10721
the cells	10724
12,000 rpm	10754
25 cm3 tissue culture flasks containing 10 % DMEM-FBS	10781
25 cm3 tissue culture flasks	10781
10 % DMEM-FBS	10821
Cells	10835
three times a week	10850
three times	10850
a week	10862
time	10903
the non purified olfactory bulb cells	10916
the non	10916
olfactory bulb cells	10933
fibroblast-like cells	10955
the major cell type	10984
the cultures	11007
lack of p75NTR expression and expression of thy1 .1 and SMA -LRB- Fig. 1 -RRB-	11035
lack	11035
p75NTR expression and expression	11043
thy1 .1 and SMA -LRB- Fig. 1 -RRB-	11079
thy1 .1 and SMA	11079
Fig. 1	11095
Skin fibroblasts Skin fibroblasts -LRB- SFs -RRB-	11104
Skin fibroblasts Skin fibroblasts	11104
Skin fibroblasts	11104
Skin fibroblasts	11121
SFs	11139
fromP7 Fischer rats using a protocol modified from Tuszynski et al. , 1996	11158
fromP7 Fischer rats	11158
a protocol modified from Tuszynski	11184
a protocol	11184
Tuszynski	11209
et al. , 1996	11219
et al.	11219
1996	11227
skin biopsies measuring 10 3 10 mm3 in size	11242
skin biopsies	11242
10 3 10 mm3 in size	11266
10 3 10 mm3	11266
size	11281
the abdominal region	11305
The biopsies	11327
131mm3 pieces	11363
the surface of PLL-coated wells of a 24 well dish	11390
the surface	11390
PLL-coated wells of a 24 well dish	11405
PLL-coated wells	11405
a 24 well dish	11425
DMEMFBS	11456
a week	11471
fibroblasts	11478
fromthe explant	11499
cellswere	11519
culture	11559
Characterization of cell cultures	11568
Characterization	11568
cell cultures	11588
passage	11605
an aliquot of cells	11614
an aliquot	11614
cells	11628
PLL coated coverslips	11650
the same optimal culture conditions as the passaged cells , and immunolabeled with markers that characterize the various cell types	11678
the same optimal culture conditions	11678
cells	11730
markers that characterize the various cell types	11760
markers	11760
the various cell types	11786
Preparation for transplantation	11810
Preparation	11810
transplantation	11826
the day of cell transplantation	11845
the day	11845
cell transplantation	11856
the various cell types	11878
the flask	11923
centrifugation	11958
300g	11976
5 min	11985
Cells	11992
ice	12011
transplantation	12021
immunocytochemical characterization of the transplanted cells	12042
immunocytochemical characterization	12042
the transplanted cells	12081
a sample of each cell culture	12105
a sample	12105
each cell culture	12117
PLL coated coverslips	12151
olfactory mucosal cells which were plated onto 10 µg/cm2 collagen I-coated coverslips	12184
olfactory mucosal cells	12184
10 µg/cm2 collagen I-coated coverslips	12231
10 µg/cm2 collagen	12231
I-coated coverslips	12250
Immunocytochemisty Characterization and assessment of the purity of cell cultures	12271
Immunocytochemisty Characterization and assessment	12271
the purity of cell cultures	12325
the purity	12325
cell cultures	12339
cells plated on PLL coated coverslips	12372
cells	12372
PLL coated coverslips	12388
The same methods and panel of markers	12411
The same methods	12411
panel of markers	12432
panel	12432
markers	12441
label cells prepared at passage and at the time of transplantation	12461
label cells	12461
passage	12485
the time of transplantation	12500
the time	12500
transplantation	12512
Primary antibodies	12529
neural cells -LRB- nestin ,1 : 200 , IgG1 , Chemicon and TUJ-1 , b tubulin isotype III , 1:500 , IgG2a , Covance -RRB- ; glial cells -LRB- p75NTR hybridoma , 1:1 ; IgG1 Yan and Johnson , 1988 -RRB- ;	12569
neural cells -LRB- nestin ,1 : 200 , IgG1 , Chemicon and TUJ-1 , b tubulin isotype III , 1:500 , IgG2a , Covance -RRB-	12569
neural cells	12569
nestin ,1 : 200 , IgG1 , Chemicon and TUJ-1 , b tubulin isotype III , 1:500 , IgG2a , Covance	12583
nestin ,1 : 200 , IgG1 , Chemicon and TUJ-1	12583
nestin ,1	12583
200 , IgG1 , Chemicon and TUJ-1	12592
200	12592
IgG1	12597
Chemicon	12603
TUJ-1	12616
b tubulin isotype III	12623
b tubulin isotype	12623
III	12641
1:500	12646
IgG2a , Covance	12653
IgG2a	12653
Covance	12660
glial cells -LRB- p75NTR hybridoma , 1:1 ; IgG1 Yan and Johnson , 1988 -RRB-	12670
glial cells	12670
p75NTR hybridoma , 1:1 ; IgG1 Yan and Johnson , 1988	12683
p75NTR hybridoma	12683
1:1 ; IgG1 Yan and Johnson	12701
1:1	12701
IgG1 Yan and Johnson	12706
IgG1 Yan	12706
Johnson	12719
1988	12728
muscle cells and fibroblasts	12746
-LSB- SMA , 1:200 , IgG1 , Sigma	12775
-LSB- SMA	12775
1:200	12781
IgG1	12788
Sigma	12794
Xu et al. , 1997 ; Dugina et al. , 1998 ; Hinz et al. , 2001 ; fibronectin -LRB- 1:100 , Dako -RRB- ; and Thy1 .1 / CD90 -LRB- 1:100 ; IgG1 , Serotec -RRB-	12801
Xu	12801
et al. , 1997 ; Dugina et al. , 1998 ; Hinz et al. , 2001 ; fibronectin -LRB- 1:100 , Dako -RRB- ; and Thy1 .1 / CD90 -LRB- 1:100 ; IgG1 , Serotec -RRB-	12804
et al. , 1997 ; Dugina et al. , 1998 ; Hinz et al. , 2001 ; fibronectin -LRB- 1:100 , Dako -RRB- ; and Thy1 .1 / CD90	12804
et al. , 1997	12804
et al.	12804
1997	12812
Dugina et al. , 1998	12818
Dugina	12818
et al. , 1998	12825
et al.	12825
1998	12833
Hinz et al. , 2001	12839
Hinz	12839
et al. , 2001	12844
et al.	12844
2001	12852
fibronectin -LRB- 1:100 , Dako -RRB- ; and Thy1 .1 / CD90	12858
fibronectin -LRB- 1:100 , Dako -RRB- ; and Thy1 .1 /	12858
fibronectin -LRB- 1:100 , Dako -RRB-	12858
fibronectin	12858
1:100	12871
Dako	12878
Thy1 .1	12889
CD90	12896
1:100	12902
IgG1 , Serotec	12909
IgG1	12909
Serotec	12915
The primary antibody	12926
the appropriate fluorochrome-conjugated secondary antibody	12963
methanol for 20 min	13035
methanol	13035
20 min	13048
220 C	13058
several washes	13071
the intracellular-antigen antibodies	13087
their appropriate secondary antibodies	13147
Primary antibodies	13187
60 min and secondary antibodies for 30 min	13221
60 min and secondary antibodies	13221
30 min	13257
room temperature -LRB- RT -RRB-	13272
room temperature	13272
RT	13290
Secondary antibodies	13295
fluorescein or rhodamine -LRB- Southern Biotechniques , Cambridge Biosciences -RRB-	13335
fluorescein or rhodamine	13335
Southern Biotechniques	13361
Cambridge Biosciences	13385
1:100	13420
HBSS containing 5 % donor calf serum -LRB- AutogenBioclear , UK -RRB- with Hepes -LRB- Gibco , Invitrogen -RRB-	13427
HBSS	13427
5 %	13443
donor calf serum -LRB- AutogenBioclear , UK -RRB-	13446
donor calf serum	13446
AutogenBioclear	13464
UK	13481
Hepes -LRB- Gibco , Invitrogen -RRB-	13490
Hepes	13490
Gibco	13497
Invitrogen	13504
staining solution	13529
the antibody stocks and wash between incubations	13557
the antibody stocks and wash	13557
incubations	13594
Cells on coverslips	13607
Cells	13607
coverslips	13616
VectaShield -LRB- Vector laboratories , Peterborough , UK -RRB- containing 406-diamidine	13643
VectaShield -LRB- Vector laboratories , Peterborough , UK -RRB-	13643
VectaShield	13643
Vector laboratories	13656
Peterborough	13677
UK	13691
2-phenylindole-dihydrochloride -LRB- DAPI -RRB-	13721
2-phenylindole-dihydrochloride	13721
DAPI	13753
nuclei	13772
Image Analysis Immunofluorescence images of the different cell type cultures	13780
Image Analysis Immunofluorescence images	13780
the different cell type cultures	13824
a Zeiss Axioskop 50B epifluorescence microscope equipped with a CCD camera -LRB- Princeton Instruments -RRB- and Metamorph 6.1 software -LRB- Molecular Devices Ltd , Berkshire , UK -RRB-	13874
a Zeiss Axioskop 50B epifluorescence microscope	13874
a CCD camera -LRB- Princeton Instruments -RRB- and Metamorph 6.1 software -LRB- Molecular Devices Ltd , Berkshire , UK -RRB-	13936
a CCD camera -LRB- Princeton Instruments -RRB-	13936
a CCD camera	13936
Princeton Instruments	13950
Metamorph 6.1 software -LRB- Molecular Devices Ltd , Berkshire , UK -RRB-	13977
Metamorph 6.1 software	13977
Molecular Devices Ltd , Berkshire , UK	14001
Cell type quantification	14040
all cell cultures	14084
each experiment	14106
a minimum of two coverslips	14123
a minimum	14123
two coverslips	14136
each cell marker	14169
a minimum of 400 DAPI labeled nuclei counted per coverslip	14191
a minimum	14191
400 DAPI labeled nuclei counted per coverslip	14204
400 DAPI	14204
nuclei counted per coverslip	14221
nuclei	14221
coverslip	14240
Data for each marker	14251
Data	14251
each marker	14260
4 to 5 separate experiments	14290
Lesioning and Cell Transplantation Thirty-three adult male Fischer 344 rats	14319
Lesioning and Cell	14319
Thirty-three adult male Fischer 344 rats	14354
a bilateral dorsal column lesion using a wire knife device -LRB- David Kopf Instruments , Tujunga -RRB- as described previously -LRB- Toft et al. , 2007 -RRB-	14413
a bilateral dorsal column lesion	14413
a wire knife device -LRB- David Kopf Instruments , Tujunga -RRB- as described previously -LRB- Toft et al. , 2007 -RRB-	14452
a wire knife device -LRB- David Kopf Instruments , Tujunga -RRB- as described previously	14452
a wire knife device	14452
David Kopf Instruments	14473
Tujunga	14497
Toft	14531
et al. , 2007	14536
et al.	14536
2007	14544
animals	14560
halothane and the L3/4	14592
halothane	14592
the L3/4	14606
spinal segmental border exposed by laminectomy	14615
spinal segmental border	14615
laminectomy	14650
The wire knife	14663
the left dorsal root entry zone	14696
an arc encompassing the dorsal columns	14747
an arc	14747
the dorsal columns	14767
a glass rod placed on the surface of the cord , cutting through the dorsal columns	14805
a glass rod	14805
the surface of the cord	14827
the surface	14827
the cord	14842
the dorsal columns	14868
the same operation	14891
animals where biotinylated dextran amine -LRB- BDA -RRB- tract tracer was to be used to investigate regeneration -LRB- see below -RRB-	14915
animals	14915
dextran amine -LRB- BDA -RRB- tract tracer was to be used to investigate regeneration -LRB- see below -RRB-	14942
dextran amine -LRB- BDA -RRB- tract tracer was to be used to investigate regeneration	14942
dextran amine	14942
BDA	14957
tract tracer	14962
regeneration	15005
the left L3 dorsal root	15031
order	15066
the possibility of tracer being transported along anastomosing afferent fibers in adjacent roots	15081
the possibility	15081
tracer being transported along anastomosing afferent fibers in adjacent roots	15100
tracer	15100
anastomosing afferent fibers in adjacent roots	15131
anastomosing afferent fibers	15131
adjacent roots	15163
Cells	15179
the gap created by the wire knife immediately after lesioning by injection of a cell suspension as described previously -LRB- Toft et al. , 2007 -RRB-	15208
the gap	15208
the wire knife	15227
injection of a cell suspension as described previously -LRB- Toft et al. , 2007 -RRB-	15273
injection	15273
a cell suspension as described previously -LRB- Toft et al. , 2007 -RRB-	15286
a cell suspension	15286
Toft	15329
et al. , 2007	15334
et al.	15334
2007	15342
cell suspensions	15358
a glass pipette	15395
a fine beveled tip -LRB- inside diameter 60 -- 70 µm -RRB-	15416
a fine beveled tip	15416
diameter 60 -- 70 µm	15443
diameter 60	15443
70 µm	15455
The pipette	15463
the lesion	15493
small slits in the dura either side of the central vein	15512
small slits	15512
the dura either side of the central vein	15527
the dura	15527
either side of the central vein	15536
either side	15536
the central vein	15551
Cell suspensions	15569
approximately 100,000	15602
cells/µL	15624
brief pressure pulses -LRB- Picoinjector , WPI , Sarasota -RRB- over the course of several minutes , during which the pipette was gradually raised to the surface	15659
brief pressure pulses	15659
Picoinjector	15682
WPI	15696
Sarasota	15701
the course of several minutes , during which the pipette was gradually raised to the surface	15716
the course	15716
several minutes , during which the pipette was gradually raised to the surface	15730
several minutes	15730
the pipette	15760
the surface	15796
cells	15812
the lesion	15849
The lesion site	15861
10-0 -LRB- Ethicon , Johnson and Johnson -RRB- surgical sutures to close the dura	15894
10-0	15894
Ethicon	15900
Johnson and Johnson	15909
surgical sutures	15930
the dura	15956
Wounds	15966
layers and animals	15988
an analgesic -LRB- Vetergesic , Alstoe , UK ; 0.06 mg , s.c. -RRB-	16026
an analgesic	16026
Vetergesic , Alstoe	16040
Vetergesic	16040
Alstoe	16052
UK ; 0.06 mg , s.c.	16060
UK	16060
0.06 mg , s.c.	16064
0.06 mg	16064
s.c.	16073
Intercellular Interaction in Nonlesioned Cord	16080
Intercellular Interaction	16080
Nonlesioned Cord	16109
addition to the dorsal column	16129
addition	16129
the dorsal column	16141
animals	16168
cells	16177
the spinal cords of 11 normal uninjured animals	16207
the spinal cords	16207
11 normal uninjured animals	16227
the direct interaction between the transplanted cells and the host astrocytes	16266
the direct interaction	16266
the transplanted cells and the host astrocytes	16297
the transplanted cells	16297
the host astrocytes	16324
Animals	16345
halothane and the fourth lumbar spinal segment exposed by laminectomy at the T13/L1 vertebral junction	16377
halothane	16377
the fourth lumbar spinal segment exposed by laminectomy at the T13/L1 vertebral junction	16391
the fourth lumbar spinal segment	16391
laminectomy	16435
the T13/L1 vertebral junction	16450
Cells	16481
pressure injected through beveled glass pipettes -LRB- inner tip diameter 60 -- 70 µm -RRB-	16492
pressure	16492
beveled glass pipettes -LRB- inner tip diameter 60 -- 70 µm -RRB-	16518
beveled glass pipettes	16518
inner tip diameter	16542
60 -- 70 µm	16561
60	16561
70 µm	16564
Pipettes	16572
approximately 1 lL of a thick cell suspension -LRB- ca. 100,000 cells/lL -RRB-	16598
approximately 1 lL	16598
a thick cell suspension -LRB- ca. 100,000 cells/lL -RRB-	16620
a thick cell suspension	16620
ca. 100,000 cells/lL	16645
ca.	16645
100,000 cells/lL	16649
the left	16685
dorsal columns	16707
These sites	16723
the surface central vein	16764
the left and right sides of the cord	16792
the left and right sides	16792
the cord	16820
an angle of 25 ° -LRB- pipette tip pointing medially -RRB-	16836
an angle	16836
25 °	16848
pipette tip pointing medially	16853
pipette tip	16853
Wounds	16885
layers and animals routinely administered an analgesic -LRB- Vetergesic , Alstoe , UK ; 0.06 mg , s.c. -RRB-	16907
layers and animals	16907
an analgesic -LRB- Vetergesic , Alstoe , UK ; 0.06 mg , s.c. -RRB-	16949
an analgesic	16949
Vetergesic , Alstoe	16963
Vetergesic	16963
Alstoe	16975
UK ; 0.06 mg , s.c.	16983
UK	16983
0.06 mg , s.c.	16987
0.06 mg	16987
s.c.	16996
Tract Tracing	17003
12 animals	17020
regeneration of ascending dorsal column axons	17032
regeneration	17032
dorsal column axons	17058
BDA -LRB- 10,000 MW ,	17116
BDA	17116
10,000 MW	17121
product no	17132
D-1956	17144
Invitrogen	17152
2 weeks	17173
perfusion	17188
The left L4 and L5 spinal nerves	17211
The left L4	17211
L5 spinal nerves	17227
the level of the iliac crest	17260
the level	17260
the iliac crest	17273
surgical anaesthesia	17295
Each nerve	17317
pressure injected -LRB- Picoinjector , see above -RRB- through fine beveled glass pipettes -LRB- tip 40 -- 50 µm internal diameter -RRB- with 3 -- 4 lL of a solution of 20 % BDA in 0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green dye added -LRB- to detect spillage of the tracer -RRB-	17332
pressure	17332
Picoinjector ,	17351
fine beveled glass pipettes -LRB- tip 40 -- 50 µm internal diameter -RRB-	17384
fine beveled glass pipettes	17384
tip 40	17413
50 µm internal diameter	17420
50 µm	17420
internal diameter	17426
3	17450
4 lL of a solution of 20 % BDA in 0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green	17452
4 lL	17452
a solution of 20 % BDA in 0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green	17460
a solution	17460
20 % BDA in 0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green	17474
20 % BDA	17474
0.1 M phosphate buffer -LRB- PB -RRB- , with 2 % fast green	17485
0.1 M phosphate buffer	17485
PB	17509
2 % fast green	17519
2 %	17519
spillage of the tracer	17554
spillage	17554
the tracer	17566
injection	17585
wounds	17596
layers and analgesia administered as above	17618
layers and analgesia	17618
Histological Processing of Spinal Cord	17662
Histological Processing	17662
Spinal Cord	17689
survival periods of 10 days -LRB- cell injections into normal cord -RRB- or 6 weeks -LRB- cell transplants into lesioned cord -RRB-	17707
survival periods	17707
10 days -LRB- cell injections into normal cord -RRB- or 6 weeks -LRB- cell transplants into lesioned cord -RRB-	17727
10 days -LRB- cell injections into normal cord -RRB-	17727
cell injections into normal cord	17736
cell injections	17736
normal cord	17757
6 weeks -LRB- cell transplants into lesioned cord -RRB-	17773
cell transplants into lesioned cord	17782
cell transplants	17782
lesioned cord	17804
animals	17820
intraperitoneal sodium pentobarbital -LRB- Euthatal , Vericore , UK ; 200 mg/mL -RRB-	17859
intraperitoneal sodium pentobarbital	17859
Euthatal , Vericore , UK ; 200 mg/mL	17897
Euthatal , Vericore , UK	17897
200 mg/mL	17921
the left ventricle	17953
mammalian Ringer 's solution	17977
mammalian Ringer 's	17977
0.1 % lidocaine	18017
4 % paraformaldehyde	18067
0.1 M PF , pH 7.4	18090
0.1 M PF	18090
pH 7.4	18100
A block of tissue encompassing the lesion/transplant or injection sites	18108
A block	18108
tissue encompassing the lesion/transplant or injection sites	18119
tissue	18119
the lesion/transplant or injection sites	18139
post-fixed overnight in the same fixative	18196
post-fixed overnight	18196
the same fixative	18220
30 % sucrose	18243
70 µm sections encompassing the lesion/injection sites	18256
70 µm sections	18256
the lesion/injection sites	18284
a freezing microtome	18323
30 min	18376
50 % ethanol then washed for 10 min in 0.3 M phosphatebuffered saline -LRB- PBS -RRB-	18386
50 % ethanol	18386
10 min in 0.3 M phosphatebuffered saline -LRB- PBS -RRB-	18414
10 min	18414
0.3 M phosphatebuffered saline -LRB- PBS -RRB-	18424
0.3 M	18424
saline -LRB- PBS -RRB-	18448
saline	18448
PBS	18456
Sections	18462
72 h	18495
4 C in different combinations of the following primary antibodies : sheep anti-GFP -LRB- Biogenesis ; 1:1,000 -RRB- , mouse anti-GFAP -LRB- Sigma , UK ; 1:1,000 -RRB- , rabbit anti-GFAP -LRB- DAKO ; 1:1,000 -RRB- , mouse/rabbit anti-NF200 -LRB- 1:1,000 , Sigma -RRB- , mouse anti-nestin -LRB- 1:400 , DSHB , IOWA -RRB- , goat anti-P0 -LRB- 1:100 Santa-Cruz -RRB- and rabbit anti-neurofascin -LRB- 1:400 , gift from Prof. P. Brophy , University of Edinburgh , UK -RRB-	18503
4 C	18503
different combinations of the following primary antibodies : sheep anti-GFP -LRB- Biogenesis ; 1:1,000 -RRB- , mouse anti-GFAP -LRB- Sigma , UK ; 1:1,000 -RRB- , rabbit anti-GFAP -LRB- DAKO ; 1:1,000 -RRB- , mouse/rabbit anti-NF200 -LRB- 1:1,000 , Sigma -RRB- , mouse anti-nestin -LRB- 1:400 , DSHB , IOWA -RRB- , goat anti-P0 -LRB- 1:100 Santa-Cruz -RRB- and rabbit anti-neurofascin -LRB- 1:400 , gift from Prof. P. Brophy , University of Edinburgh , UK -RRB-	18510
different combinations of the following primary antibodies	18510
different combinations	18510
the following primary antibodies	18536
sheep anti-GFP -LRB- Biogenesis ; 1:1,000 -RRB- , mouse anti-GFAP -LRB- Sigma , UK ; 1:1,000 -RRB- , rabbit anti-GFAP -LRB- DAKO ; 1:1,000 -RRB- , mouse/rabbit anti-NF200 -LRB- 1:1,000 , Sigma -RRB- , mouse anti-nestin -LRB- 1:400 , DSHB , IOWA -RRB- , goat anti-P0 -LRB- 1:100 Santa-Cruz -RRB- and rabbit anti-neurofascin -LRB- 1:400 , gift from Prof. P. Brophy , University of Edinburgh , UK -RRB-	18570
sheep anti-GFP -LRB- Biogenesis ; 1:1,000 -RRB-	18570
sheep anti-GFP	18570
Biogenesis ; 1:1,000	18586
Biogenesis	18586
1:1,000	18598
mouse anti-GFAP -LRB- Sigma , UK ; 1:1,000 -RRB-	18608
mouse anti-GFAP	18608
Sigma , UK ; 1:1,000	18625
Sigma , UK	18625
1:1,000	18636
rabbit anti-GFAP -LRB- DAKO ; 1:1,000 -RRB-	18646
rabbit anti-GFAP	18646
DAKO ; 1:1,000	18664
DAKO	18664
1:1,000	18670
mouse/rabbit anti-NF200 -LRB- 1:1,000 , Sigma -RRB-	18680
mouse/rabbit anti-NF200	18680
1:1,000	18705
Sigma	18714
mouse anti-nestin -LRB- 1:400 , DSHB , IOWA -RRB-	18722
mouse anti-nestin	18722
1:400	18741
DSHB	18748
IOWA	18754
goat anti-P0 -LRB- 1:100 Santa-Cruz -RRB-	18761
goat anti-P0	18761
1:100 Santa-Cruz	18775
1:100	18775
Santa-Cruz	18781
rabbit anti-neurofascin -LRB- 1:400 , gift from Prof. P. Brophy , University of Edinburgh , UK -RRB-	18797
rabbit anti-neurofascin	18797
1:400 , gift from Prof. P. Brophy , University of Edinburgh , UK	18822
1:400	18822
gift from Prof. P. Brophy , University of Edinburgh	18829
gift	18829
Prof. P. Brophy , University of Edinburgh	18839
Prof. P. Brophy	18839
University of Edinburgh	18856
University	18856
Edinburgh	18870
UK	18881
addition	18889
tissue where BDA tracer was to be detected	18902
tissue	18902
BDA tracer	18915
streptavidin conjugated to dichloratriazinylamino fluorescein -LRB- DTAF ; 1:1,000 , Jackson -RRB-	18946
streptavidin	18946
dichloratriazinylamino fluorescein -LRB- DTAF ; 1:1,000 , Jackson -RRB-	18973
dichloratriazinylamino fluorescein	18973
DTAF ; 1:1,000 , Jackson	19009
DTAF	19009
1:1,000 , Jackson	19015
1:1,000	19015
Jackson	19024
place of one of the antibodies in the primary antibody cocktail	19052
place	19052
one of the antibodies in the primary antibody cocktail	19061
one	19061
the antibodies in the primary antibody cocktail	19068
the antibodies	19068
the primary antibody cocktail	19086
Sections	19117
fluorophore	19157
species-specific donkey IgG secondary antibodies for 4 h	19181
species-specific donkey IgG secondary antibodies	19181
4 h	19234
room temperature	19241
All antibodies	19259
PBS	19290
0.3 % triton X-100	19299
Sections	19318
plain glass slides	19345
VectaShield -LRB- Vector laboratories -RRB-	19370
VectaShield	19370
Vector laboratories	19383
220 °C	19418
Epifluorescence and Confocal Microscopy Sections	19425
low power	19501
a Nikon Eclipse E600 epifluorescence microscope	19517
Lesion morphology , co-expression of various markers and evidence of regenerating and myelinated axons	19566
Lesion morphology , co-expression of various markers	19566
Lesion morphology	19566
co-expression of various markers	19585
co-expression	19585
various markers	19602
evidence of regenerating and myelinated axons	19622
evidence	19622
regenerating and myelinated axons	19634
regenerating	19634
myelinated axons	19651
sections	19689
the tissue	19741
5 µm -LRB- 43 -RRB- , 2 µm -LRB- 203 -RRB- , or 0.5 µm -LRB- 603 , oil immersion -RRB-	19755
5 µm -LRB- 43 -RRB-	19755
43	19761
2 µm -LRB- 203 -RRB-	19766
203	19772
0.5 µm -LRB- 603 , oil immersion -RRB-	19781
603	19789
oil immersion	19794
intervals using a Bio-Rad MRC1024 confocal system	19809
intervals	19809
a Bio-Rad MRC1024 confocal system	19825
The resulting Z-series ' and projections of these confocal image stacks -LRB- formed using Confocal Assistant software , Todd Clark Brelje , University of Minnesota -RRB- were examined for notable features such as marker co-expression and whether labeled axons	19860
Z-series '	19874
projections of these confocal image stacks -LRB- formed using Confocal Assistant software , Todd Clark Brelje , University of Minnesota -RRB-	19888
projections of these confocal image stacks	19888
projections	19888
these confocal image stacks	19903
Confocal Assistant software , Todd Clark Brelje , University of Minnesota	19945
Confocal Assistant software	19945
Todd Clark Brelje	19974
University of Minnesota	19993
University	19993
Minnesota	20007
notable features such as marker co-expression and whether labeled axons	20036
notable features such as marker co-expression	20036
notable features	20036
marker co-expression	20061
the cell transplant	20116
the lesion site	20139
the dorsal column lesion	20178
Images selected for illustration	20204
Images	20204
illustration	20224
Adobe Photoshop CS2	20254
publication	20292
Quantification of Length of Lesion Site	20305
Quantification	20305
Length of Lesion Site	20323
Length	20323
Lesion Site	20333
the rostro-caudal extent of the lesion environment	20366
the rostro-caudal extent	20366
the lesion environment	20394
different cell preparations	20431
the lesion site	20477
we	20493
the extent of the lesion perimeter	20505
the extent	20505
the lesion perimeter	20519
6 weeks	20540
lesioning and transplantation	20554
GFAP expression	20585
the glial scar	20609
the perimeter of the transplanted lesion	20631
the perimeter	20631
the transplanted lesion	20648
GFAP immunolabeling	20673
the section	20724
each animal showing the greatest distance between rostral and caudal lesion perimeters	20741
each animal	20741
the greatest distance between rostral and caudal lesion perimeters	20761
the greatest distance	20761
rostral and caudal lesion perimeters	20791
GFAP immunoreactivity -LRB- IR -RRB-	20829
GFAP immunoreactivity	20829
IR	20852
a Nikon Eclipse E600 epifluorescence microscope attached to a digital camera -LRB- Axiocam , Zeiss -RRB- and Zeiss Axiovision v3 .0 software	20879
a Nikon Eclipse E600 epifluorescence microscope	20879
a digital camera -LRB- Axiocam , Zeiss -RRB- and Zeiss Axiovision v3 .0 software	20939
a digital camera -LRB- Axiocam , Zeiss -RRB-	20939
a digital camera	20939
Axiocam	20957
Zeiss	20966
Zeiss Axiovision v3 .0 software	20977
Zeiss Axiovision	20977
v3 .0 software	20994
Digital images	21009
ImageJ software -LRB- NIH Image , Rasband , W.S. , ImageJ , U. S. National Institutes of Health , Bethesda , Maryland , USA , http://rsb.info.nih.gov/ij/ , 1997 -- 2007 -RRB-	21041
ImageJ software	21041
NIH Image , Rasband , W.S. , ImageJ , U. S. National Institutes of Health , Bethesda , Maryland , USA , http://rsb.info.nih.gov/ij/ , 1997 -- 2007	21058
NIH Image	21058
Rasband , W.S. , ImageJ , U. S. National Institutes of Health , Bethesda , Maryland , USA , http://rsb.info.nih.gov/ij/	21069
Rasband , W.S. , ImageJ , U. S.	21069
National Institutes of Health , Bethesda , Maryland , USA , http://rsb.info.nih.gov/ij/	21098
Health , Bethesda , Maryland , USA ,	21121
1997 -- 2007	21183
the distance between the rostral and caudal perimeters of the glial reaction	21205
the distance between the rostral	21205
the distance	21205
the rostral	21226
caudal perimeters of the glial reaction	21242
caudal perimeters	21242
the glial reaction	21263
Statistical analyses	21283
GraphPad Prism	21325
v4 .03	21340
One-way ANOVA with Tukey-Kramer	21347
One-way ANOVA	21347
Tukey-Kramer	21366
hoc testing was used to test for significant differences between lesion lengths	21384
hoc	21384
testing	21388
significant differences between lesion lengths	21417
significant differences	21417
lesion lengths	21449
Quantification of Density of Regenerating Axons Regeneration into each cell transplant	21465
Quantification	21465
Density of Regenerating Axons Regeneration into each cell transplant	21483
Density	21483
Axons Regeneration	21507
each cell transplant	21531
6 weeks	21573
the density of neurofilament positive axons	21596
the density	21596
neurofilament positive axons	21611
confocal image stacks of transplant sites	21643
confocal image stacks	21643
transplant sites	21668
ImageJ software	21691
The volume of lesion	21708
The volume	21708
lesion	21722
transplant site	21730
GFAP IR	21770
a border along which a contour line was drawn using the `` Freehand selections '' tool	21788
a border	21788
a contour line	21809
the `` Freehand selections '' tool	21840
The area within this contour	21874
The area	21874
this contour	21890
the number of sections within the image	21921
the number	21921
sections within the image	21935
sections	21935
the image	21951
the z-depth between each zsection within the	21971
the z-depth	21971
each zsection within the	21991
each zsection	21991
a volume in µm3	22032
a volume	22032
µm3	22044
The density of neurofilament axons	22049
The density	22049
neurofilament axons	22064
the ImageJ	22116
Threshold '' and `` Skeletonize ''	22129
Threshold	22129
Skeletonize	22147
tools to convert stacks of labeled axons into stacks of 1 pixel thick profiles	22161
stacks of labeled axons into stacks of 1 pixel thick profiles	22178
stacks	22178
axons	22196
stacks of 1 pixel thick profiles	22207
stacks	22207
1 pixel thick profiles	22217
Quantification of the total length of profiles within each	22241
Quantification	22241
the total length of profiles within each	22259
the total length	22259
profiles within each	22279
profiles	22279
each	22295
the `` Analyze Particles '' function	22330
Particles	22344
The density of axon in-growth	22366
The density	22366
axon in-growth	22381
the total length of neurofilament positive axons in µm , per µm3 of transplant site	22414
the total length	22414
neurofilament positive axons in µm , per µm3 of transplant site	22434
neurofilament positive axons	22434
µm	22466
µm3 of transplant site	22474
µm3	22474
transplant site	22481
Significant differences	22498
one-way ANOVA	22541
Tukey	22560
Kramer post hoc testing	22566
RESULTS	22592
1	22606
Immunocytochemical Characterization of Cell Preparations Fig. 1 .	22609
Immunocytochemical Characterization of Cell Preparations	22609
Immunocytochemical Characterization	22609
Cell Preparations	22648
Fig. 1	22667
Fig.	22667
1	22672
Immunocytochemical labeling of cell cultures .	22675
Immunocytochemical labeling	22675
cell cultures	22706
Antigenic profile and quantification of marker positive cells/DAPI nuclei , for the types of cells	22721
Antigenic profile	22721
quantification of marker positive cells/DAPI nuclei	22743
quantification	22743
marker positive cells/DAPI nuclei	22761
the types of cells	22800
the types	22800
cells	22813
transplantation	22828
-LRB- A -- C -RRB- OECs from p7 olfactory bulb .	22845
-LRB- A -- C -RRB- OECs from p7 olfactory bulb	22845
-LRB- A -- C -RRB- OECs	22845
A -- C	22846
A	22846
C	22848
p7 olfactory bulb	22861
-LRB- D -- F -RRB- SCs from p7 sciatic nerve .	22880
-LRB- D -- F -RRB- SCs from p7 sciatic nerve	22880
-LRB- D -- F -RRB- SCs	22880
D -- F	22881
D	22881
F	22883
p7 sciatic nerve	22895
-LRB- G -RRB- fibroblast-like cells from p7 olfactory bulb , -LRB- H -RRB- PNFB-like cells from P7 sciatic nerve , -LRB- I -RRB- fibroblast-like cells from abdominal skin , -LRB- J -- L -RRB- mixed cells from p7 olfactory mucosa .	22913
-LRB- G -RRB-	22913
fibroblast-like cells from p7 olfactory bulb , -LRB- H -RRB-	22917
fibroblast-like cells	22917
p7 olfactory bulb , -LRB- H -RRB-	22944
p7 olfactory bulb	22944
H	22964
PNFB-like cells from P7 sciatic nerve , -LRB- I -RRB-	22967
PNFB-like cells	22967
P7 sciatic nerve , -LRB- I -RRB-	22988
P7 sciatic nerve	22988
I	23007
fibroblast-like cells from abdominal skin , -LRB- J -- L -RRB-	23010
fibroblast-like cells	23010
abdominal skin , -LRB- J -- L -RRB-	23037
abdominal skin	23037
J -- L	23054
J	23054
L	23056
mixed cells from p7 olfactory mucosa	23059
mixed cells	23059
p7 olfactory mucosa	23076
Scale bar 10 µm -LRB- A -- C , G , I , L , and K -RRB- scale bar 25 µm -LRB- D -- F , H , and J -RRB- .	23097
Scale bar 10 µm -LRB- A -- C , G , I , L , and K -RRB-	23097
Scale	23097
10 µm -LRB- A -- C , G , I , L , and K -RRB-	23107
10 µm	23107
A -- C , G , I , L , and K	23114
C , G , I , L , and K	23116
C	23116
G	23119
I	23122
L	23125
K	23132
scale bar 25 µm -LRB- D -- F , H , and J -RRB-	23135
scale bar	23135
25 µm -LRB- D -- F , H , and J -RRB-	23145
D -- F , H , and J	23152
D	23152
F , H , and J	23154
OEC , OECs ; OBFB-L , olfactory bulb fibroblast-like cells ; OM , mixed olfactory mucosa cells ; SC , Schwann cells ; PNFB , peripheral nerve fibroblast ; SF , skin fibroblasts .	23168
OEC , OECs	23168
OEC	23168
OECs	23173
OBFB-L , olfactory bulb fibroblast-like cells	23179
OBFB-L	23179
olfactory bulb fibroblast-like cells	23187
OM , mixed olfactory mucosa cells	23225
OM	23225
mixed olfactory mucosa cells	23229
SC , Schwann cells	23259
SC	23259
Schwann cells	23263
PNFB , peripheral nerve fibroblast	23278
PNFB	23278
peripheral nerve fibroblast	23284
SF , skin fibroblasts	23313
SF	23313
skin fibroblasts	23317
Fn -LRB- Fibronectin -RRB- ; SMA , Thy1 -LRB- Thymocyte differentiation antigen 1.1 -RRB- and TUJ-1 -LRB- b III tubulin -RRB- .	23335
Fn	23335
Fibronectin	23339
SMA , Thy1 -LRB- Thymocyte differentiation antigen 1.1 -RRB- and TUJ-1 -LRB- b III tubulin -RRB-	23353
SMA	23353
Thy1 -LRB- Thymocyte differentiation antigen 1.1 -RRB- and TUJ-1 -LRB- b III tubulin -RRB-	23358
Thy1 -LRB- Thymocyte differentiation antigen 1.1 -RRB-	23358
Thy1	23358
Thymocyte differentiation antigen 1.1	23364
Thymocyte differentiation antigen	23364
1.1	23398
TUJ-1 -LRB- b III tubulin -RRB-	23407
TUJ-1	23407
b III tubulin	23414
-LSB- Color figure	23430
the online issue , which is available at wileyonlinelibrary.com	23461
the online issue	23461
wileyonlinelibrary.com	23501
Fig. 2 .	23527
Fig.	23527
2	23532
Axonal regeneration into transplanted cells	23535
Axonal regeneration	23535
transplanted cells	23560
anti-neurofilament	23594
Panels A -- G show montages built from several confocal images of representative sagittal sections from the lesion sites of animals	23614
Panels	23614
A -- G show montages	23621
G show	23623
several confocal images of representative sagittal sections	23650
several confocal images	23650
representative sagittal sections	23677
the lesion sites of animals	23715
the lesion sites	23715
animals	23735
each cell preparation	23761
Neurofilament-200 labeling -LRB- red -RRB-	23784
Neurofilament-200 labeling	23784
red	23812
regenerating axons	23836
GFAP staining -LRB- blue -RRB-	23861
GFAP staining	23861
blue	23876
the glial scar delineating the lesion/graft site	23890
the glial scar	23890
the lesion/graft site	23917
regeneration	23952
each transplant	23968
the density of neurofilamentlabeled axons -LRB- µm of axon per µm3 transplant site -RRB-	23985
the density of neurofilamentlabeled axons	23985
the density	23985
neurofilamentlabeled axons	24000
µm of axon per µm3 transplant site	24028
µm	24028
axon	24034
µm3 transplant site	24043
confocal image stacks	24080
-LRB- H -RRB- Quantification of the density of neurofilament positive axons in each transplant .	24103
Quantification	24107
the density	24125
neurofilament positive axons	24140
each transplant	24172
Scatter plots	24189
mean 6 SD	24208
Oneway ANOVA with Tukey-Kramer post	24219
Oneway ANOVA	24219
Tukey-Kramer post	24237
hoc testing showed significant differences between OECs and OBFB-L	24255
hoc	24255
testing	24259
significant differences between OECs and OBFB-L	24274
significant differences	24274
OECs and OBFB-L	24306
P < 0.001 , *** -RRB- , OEC/OBFB-L -LRB- P < 0.01 , ** -RRB- , and SF -LRB- P < 0.05 , * -RRB- and significant differences between SCs and OBFB-L transplants -LRB- P < 0.05 , *	24323
P < 0.001 , *** -RRB-	24323
P	24323
0.001 , ***	24327
0.001	24327
***	24334
OEC/OBFB-L -LRB- P < 0.01 , ** -RRB- , and SF -LRB- P < 0.05 , * -RRB-	24340
OEC/OBFB-L -LRB- P < 0.01 , ** -RRB-	24340
OEC/OBFB-L	24340
P < 0.01 , **	24352
P	24352
< 0.01 , **	24354
<	24354
0.01 , **	24356
0.01	24356
SF -LRB- P < 0.05 , * -RRB-	24371
SF	24371
P < 0.05 , *	24375
P	24375
< 0.05 , *	24377
<	24377
0.05 , *	24379
0.05	24379
significant differences between SCs and OBFB-L transplants -LRB- P < 0.05 , *	24392
significant differences	24392
SCs and OBFB-L transplants -LRB- P < 0.05 , *	24424
SCs	24424
OBFB-L transplants -LRB- P < 0.05	24432
OBFB-L transplants	24432
P < 0.05	24452
P <	24452
P	24452
0.05	24456
-LRB- A -- G -RRB- scale	24466
A -- G	24467
A	24467
G	24469
500 µm	24484
OECs , OECs ; OBFB-L , olfactory bulb fibroblast-like cells ; OM , mixed olfactory mucosa cells ; SCs , Schwann cells ; PNFB , peripheral nerve fibroblasts ; SF , skin fibroblasts .	24492
OECs , OECs	24492
OECs	24492
OECs	24498
OBFB-L , olfactory bulb fibroblast-like cells	24504
OBFB-L	24504
olfactory bulb fibroblast-like cells	24512
OM , mixed olfactory mucosa cells	24550
OM	24550
mixed olfactory mucosa cells	24554
SCs , Schwann cells	24584
SCs	24584
Schwann cells	24589
PNFB , peripheral nerve fibroblasts	24604
PNFB	24604
peripheral nerve fibroblasts	24610
SF , skin fibroblasts	24640
SF	24640
skin fibroblasts	24644
-LSB- Color figure	24662
the online issue , which is available at wileyonlinelibrary.com	24693
the online issue	24693
wileyonlinelibrary.com	24733
Fig. 3 .	24759
Fig.	24759
3	24764
Axonal regeneration	24767
tract tracing	24802
tract	24802
Confocal image montages of representative sagittal sections from animals	24817
Confocal image montages	24817
representative sagittal sections from animals	24844
representative sagittal sections	24844
animals	24882
different cell preparations	24908
BDA tract tracer	24937
the L4 and L5 spinal nerves	24972
the L4	24972
L5 spinal nerves	24983
dorsal column axons	25032
A -- D	25054
A	25054
D	25056
OEC , SC , PNFB and OM transplants	25059
regeneration of ascending dorsal column axons but regenerating axons	25102
regeneration	25102
dorsal column axons	25128
axons	25165
the transplant within the lesion site	25188
the transplant	25188
the lesion site	25210
The lesion boundary	25227
GFAP immunostaining for the astrocytic scar -LRB- blue -RRB-	25266
GFAP immunostaining	25266
the astrocytic scar -LRB- blue -RRB-	25290
the astrocytic scar	25290
blue	25311
BDA-labeled axons regenerating into the lesion site	25321
BDA-labeled axons	25321
the lesion site	25357
The boxed areas	25393
The	25393
areas	25403
high power -LRB- 360 -RRB- insets in each panel	25422
high power -LRB- 360 -RRB- insets	25422
360	25434
each panel	25449
Scale bar A , 1 mm .	25461
Scale bar A	25461
1 mm	25474
Scale bar A inset , 25 µm .	25480
Scale bar A inset	25480
25 µm	25499
-LSB- Color figure	25506
the online issue , which is available at wileyonlinelibrary.com	25537
the online issue	25537
wileyonlinelibrary.com	25577
Fig. 4 .	25603
Fig.	25603
4	25608
Differences in the rostro-caudal extent of lesions	25611
Differences	25611
the rostro-caudal extent of lesions	25626
the rostro-caudal extent	25626
lesions	25654
different cell types A -- G , Confocal micrographs	25680
different cell types	25680
G , Confocal micrographs	25703
G	25703
Confocal micrographs	25706
the typical rostro-caudal extent of lesions assessed using GFAP immunolabeling	25737
the typical rostro-caudal extent	25737
lesions assessed using GFAP immunolabeling	25773
lesions	25773
GFAP immunolabeling	25796
The lesion morphology	25817
different cell preparations	25864
the mean lesion length	25905
the section from each animal that showed the maximum rostro-caudal extent of the lesion was measured with the mean values 6 SD reported in H. OECs -LRB- A -RRB- and SCs -LRB- E -RRB-	25929
the section	25929
each animal that showed the maximum rostro-caudal extent of the lesion was measured with the mean values 6 SD reported in H. OECs -LRB- A -RRB- and SCs -LRB- E -RRB-	25946
each animal	25946
the maximum rostro-caudal extent of the lesion	25970
the maximum rostro-caudal extent	25970
the lesion	26006
the mean values	26035
6 SD reported in H. OECs -LRB- A -RRB- and SCs -LRB- E -RRB-	26051
6 SD	26051
H. OECs -LRB- A -RRB- and SCs -LRB- E -RRB-	26068
H. OECs	26068
A	26077
SCs	26084
E	26089
narrow lesions	26109
preparations that contained a mixture of cells	26130
preparations	26130
a mixture of cells	26158
a mixture	26158
cells	26171
fibroblasts	26188
longer lesions	26213
-LRB- H -RRB- One-way ANOVA with Tukey -- Kramer post hoc testing showed significant differences between : OECs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.05 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB- , respectively , and between SCs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.01 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB- , respectively , and between PNFB and OM -LRB- P < 0.01 -RRB- , between OBFB-L and OEC/OBFB-L -LRB- P < 0.05 -RRB- and between OEC / OBFB-L and OM -LRB- P < 0.001 -RRB- .	26229
-LRB- H -RRB- One-way ANOVA with Tukey	26229
One-way ANOVA	26233
Tukey	26252
Kramer post hoc testing showed significant differences between : OECs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.05 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB- , respectively , and between SCs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.01 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB- , respectively , and between PNFB and OM -LRB- P < 0.01 -RRB- , between OBFB-L and OEC/OBFB-L -LRB- P < 0.05 -RRB- and between OEC / OBFB-L and OM -LRB- P < 0.001 -RRB-	26258
Kramer	26258
post hoc testing	26265
significant differences	26289
: OECs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.05 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB- , respectively	26320
: OECs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.05 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB-	26320
OECs and PNFB -LRB- P < 0.001 -RRB-	26322
OECs	26322
PNFB -LRB- P < 0.001 -RRB-	26331
PNFB	26331
P < 0.001	26337
P	26337
< 0.001	26339
<	26339
0.001	26341
OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.05 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB-	26349
OBFB-L -LRB- P < 0.001 -RRB-	26349
OBFB-L	26349
P < 0.001	26357
P	26357
< 0.001	26359
<	26359
0.001	26361
OEC/OBFB-L -LRB- P < 0.05 -RRB-	26369
OEC/OBFB-L	26369
P < 0.05	26381
P	26381
< 0.05	26383
<	26383
0.05	26385
SF -LRB- P < 0.001 -RRB-	26392
SF	26392
P < 0.001	26396
P	26396
< 0.001	26398
<	26398
0.001	26400
OM -LRB- P < 0.001 -RRB-	26412
OM	26412
P < 0.001	26416
P	26416
< 0.001	26418
<	26418
0.001	26420
SCs and PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.01 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB-	26454
SCs	26454
PNFB -LRB- P < 0.001 -RRB- , OBFB-L -LRB- P < 0.001 -RRB- , OEC/OBFB-L -LRB- P < 0.01 -RRB- , SF -LRB- P < 0.001 -RRB- , and OM -LRB- P < 0.001 -RRB-	26462
PNFB -LRB- P < 0.001 -RRB-	26462
PNFB	26462
P < 0.001	26468
P	26468
< 0.001	26470
<	26470
0.001	26472
OBFB-L -LRB- P < 0.001 -RRB-	26480
OBFB-L	26480
P < 0.001	26488
P	26488
< 0.001	26490
<	26490
0.001	26492
OEC/OBFB-L -LRB- P < 0.01 -RRB-	26500
OEC/OBFB-L	26500
P < 0.01	26512
P	26512
< 0.01	26514
<	26514
0.01	26516
SF -LRB- P < 0.001 -RRB-	26523
SF	26523
P < 0.001	26527
P	26527
< 0.001	26529
<	26529
0.001	26531
OM -LRB- P < 0.001 -RRB-	26543
OM	26543
P < 0.001	26547
P	26547
< 0.001	26549
<	26549
0.001	26551
PNFB and OM -LRB- P < 0.01 -RRB- , between OBFB-L and OEC/OBFB-L -LRB- P < 0.05 -RRB-	26585
PNFB and OM	26585
P < 0.01	26598
P	26598
< 0.01	26600
<	26600
0.01	26602
OBFB-L and OEC/OBFB-L -LRB- P < 0.05 -RRB-	26617
OBFB-L and OEC/OBFB-L	26617
P < 0.05	26640
P	26640
< 0.05	26642
<	26642
0.05	26644
OEC / OBFB-L and OM -LRB- P < 0.001 -RRB-	26662
OEC / OBFB-L and OM	26662
OEC	26662
OBFB-L and OM	26667
OBFB-L	26667
OM	26678
P < 0.001	26682
P	26682
< 0.001	26684
<	26684
0.001	26686
Scale	26694
500 µm	26706
Fig. 5 .	26715
Fig.	26715
5	26720
Glial cell reaction to transplanted cells in nonlesioned cord .	26723
Glial cell reaction	26723
transplanted cells in nonlesioned cord	26746
transplanted cells	26746
nonlesioned cord	26768
The various cell preparations	26786
nonlesioned cord and sections stained with antibodies to GFAP -LRB- blue -RRB- and nestin -LRB- red -RRB- to assess the induced glial reaction	26835
nonlesioned cord and sections	26835
antibodies	26878
GFAP -LRB- blue -RRB- and nestin -LRB- red -RRB-	26892
GFAP	26892
blue	26898
nestin	26908
red	26916
the induced glial reaction	26931
-LRB- D -- F -RRB- OECs and reactive astrocyte processes	26959
-LRB- D -- F -RRB- OECs	26959
D -- F	26960
D	26960
F	26962
reactive astrocyte processes	26974
the injected area	27022
-LRB- G -- I -RRB- SCs induce less interaction of this sort and tend to be closely	27041
-LRB- G -- I -RRB- SCs	27041
G -- I	27042
G	27042
I	27044
less interaction of this sort	27058
less interaction	27058
this sort	27078
the astrocytic tissue	27125
Mixed cell preparations and those containing fibroblasts	27148
Mixed cell preparations	27148
those containing fibroblasts	27176
those	27176
fibroblasts	27193
a more pronounced glial reaction	27213
PNFB -LRB- J -- L -RRB- , OM -LRB- M -- O -RRB- , and OBFB-L -LRB- P -- R -RRB- transplants	27247
PNFB -LRB- J -- L -RRB- , OM -LRB- M -- O -RRB- , and OBFB-L -LRB- P -- R -RRB-	27247
PNFB -LRB- J -- L -RRB-	27247
PNFB	27247
J -- L	27253
J	27253
L	27255
OM -LRB- M -- O -RRB-	27259
OM	27259
M -- O	27263
M	27263
O	27265
OBFB-L -LRB- P -- R -RRB-	27273
OBFB-L	27273
P -- R	27281
P	27281
R	27283
transplants	27286
intense GFAP and nestin staining	27310
processes that radiated around the transplanted cell bolus	27348
processes	27348
the transplanted cell bolus	27379
Spinal cord injected with comparable volumes of culture medium -LRB- A -- C -RRB-	27408
Spinal cord	27408
comparable volumes of culture medium	27434
comparable volumes	27434
culture medium	27456
A -- C	27472
A	27472
C	27474
a mild glial reaction	27484
the narrow injection track	27513
the patterns of reactivity seen above	27556
the patterns	27556
reactivity seen above	27572
reactivity	27572
the transplanted cells	27613
Scale	27637
A , 400 µm -LRB- applicable to A , D , G , J , M , and P -RRB-	27647
A	27647
400 µm -LRB- applicable to A , D , G , J , M , and P -RRB-	27650
applicable to A , D , G , J , M , and P	27658
applicable to A	27658
D , G , J , M , and P	27675
Scale	27695
B , 100 µm -LRB- applicable to B&C , E&F , H&I , K&L , N&O , and Q&R -RRB-	27705
B	27705
100 µm -LRB- applicable to B&C , E&F , H&I , K&L , N&O , and Q&R -RRB-	27708
B&C , E&F , H&I , K&L , N&O , and Q&R	27730
B&C , E&F , H&I , K&L , N&O ,	27730
Q&R	27759
-LSB- Color figure	27765
the online issue , which is available at wileyonlinelibrary.com	27796
the online issue	27796
wileyonlinelibrary.com	27836
Fig. 6 .	27862
Fig.	27862
6	27867
Regenerating axons	27870
markers of nodal architecture	27916
markers	27916
nodal architecture	27927
Transplants of OECs -LRB- A -RRB- , SCs -LRB- B -RRB- , PNFBs -LRB- C -RRB- , and olfactory mucosa -LRB- D -RRB-	27947
Transplants	27947
OECs -LRB- A -RRB- , SCs -LRB- B -RRB- , PNFBs -LRB- C -RRB- , and olfactory mucosa -LRB- D -RRB-	27962
OECs -LRB- A -RRB-	27962
OECs	27962
A	27968
SCs -LRB- B -RRB-	27972
SCs	27972
B	27977
PNFBs -LRB- C -RRB-	27981
PNFBs	27981
C	27988
olfactory mucosa -LRB- D -RRB-	27996
olfactory mucosa	27996
D	28014
immunostaining for P0 -LRB- peripheral - type myelin ,	28037
immunostaining for P0 -LRB- peripheral - type myelin	28037
immunostaining	28037
P0 -LRB- peripheral -	28056
P0	28056
peripheral	28060
Many regenerating axons -LRB- neurofilament , red -RRB-	28087
Many regenerating axons	28087
neurofilament , red	28112
neurofilament	28112
red	28127
the transplants , enwrapped by P0 -LRB- green , arrows -RRB-	28157
the transplants	28157
P0 -LRB- green , arrows -RRB-	28187
P0	28187
green , arrows	28191
green	28191
arrows	28198
High power -LRB- 360 oil immersion -RRB- confocal images -LRB- E and F -RRB-	28207
High power -LRB- 360 oil immersion -RRB- confocal images	28207
High power	28207
360 oil immersion	28219
confocal images	28238
E and F	28255
E	28255
F	28261
paranodal neurofascin labeling -LRB- red -RRB- on neurofilament-positive regenerating axons -LRB- NF200 blue -RRB- within GFP-infected -LRB- green -RRB- OEC -LRB- E -RRB- and SC -LRB- F -RRB- transplants	28271
paranodal neurofascin labeling	28271
red	28303
neurofilament-positive regenerating axons -LRB- NF200 blue -RRB- within GFP-infected -LRB- green -RRB- OEC -LRB- E -RRB- and SC -LRB- F -RRB- transplants	28311
neurofilament-positive regenerating axons -LRB- NF200 blue -RRB- within GFP-infected -LRB- green -RRB- OEC -LRB- E -RRB-	28311
neurofilament-positive regenerating axons -LRB- NF200 blue -RRB-	28311
neurofilament-positive regenerating axons	28311
NF200 blue	28354
GFP-infected -LRB- green -RRB- OEC -LRB- E -RRB-	28373
GFP-infected -LRB- green -RRB- OEC	28373
E	28399
SC -LRB- F -RRB- transplants	28406
SC	28406
F	28410
transplants	28413
normal paranodal architecture -LRB- arrows -RRB-	28437
normal paranodal architecture	28437
arrows	28468
Scale	28477
A , 100 µm -LRB- applicable to A -- D -RRB-	28487
A	28487
100 µm -LRB- applicable to A -- D -RRB-	28490
A -- D	28512
D	28514
Scale	28518
E , 20 µm -LRB- applicable to E , F -RRB-	28528
E	28528
20 µm -LRB- applicable to E , F -RRB-	28531
E , F	28552
E	28552
F	28555
-LSB- Color figure	28559
the online issue , which is available at wileyonlinelibrary.com	28590
the online issue	28590
wileyonlinelibrary.com	28630
Cell Cultures A panel of markers	28656
Cell Cultures A panel	28656
Cell Cultures	28656
A panel	28670
markers	28681
the transplanted cells	28714
Quantitative results	28738
Table 1	28772
examples of immunolabeled cells	28784
examples	28784
immunolabeled cells	28796
Figure 1	28829
purification OECs and SCs	28845
97 % pure as defined by expression of the low affinity nerve	28891
97 % pure	28891
expression of the low affinity nerve	28914
expression	28914
the low affinity nerve	28928
growth factor receptor -LRB- p75NTR ; Barnett et al. , 1993 -RRB-	28951
growth factor receptor	28951
p75NTR ; Barnett et al. , 1993	28975
p75NTR	28975
Barnett et al. , 1993	28983
Barnett	28983
et al. , 1993	28991
et al.	28991
1993	28999
These cell types	29006
high levels of nestin , a marker expressed by a wide range of cell types , including stem cells , neuroepithelial cells and glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB- and associated with a reactive cell status -LRB- Lin et al. , 1995 ; Tamango and Schiffer 2006 -RRB-	29038
high levels	29038
nestin , a marker expressed by a wide range of cell types , including stem cells , neuroepithelial cells and glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB- and associated with a reactive cell status -LRB- Lin et al. , 1995 ; Tamango and Schiffer 2006 -RRB-	29053
nestin	29053
a marker expressed by a wide range of cell types , including stem cells , neuroepithelial cells and glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB- and associated with a reactive cell status -LRB- Lin et al. , 1995 ; Tamango and Schiffer 2006 -RRB-	29061
a marker	29061
a wide range of cell types , including stem cells , neuroepithelial cells and glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB-	29083
a wide range	29083
cell types	29099
stem cells , neuroepithelial cells and glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB-	29121
stem cells	29121
neuroepithelial cells	29133
glial cells -LRB- Gilyarov , 2008 ; Bramanti et al. , 2010 -RRB-	29159
glial cells	29159
Gilyarov , 2008 ; Bramanti et al. , 2010	29172
Gilyarov	29172
2008 ; Bramanti et al.	29182
2008	29182
Bramanti et al.	29188
Bramanti	29188
et al.	29197
2010	29205
a reactive cell status -LRB- Lin et al. , 1995 ; Tamango and Schiffer 2006 -RRB-	29231
a reactive cell status	29231
Lin et al. , 1995 ; Tamango and Schiffer 2006	29255
Lin	29255
et al. , 1995 ; Tamango and Schiffer 2006	29259
et al.	29259
1995	29267
Tamango	29273
Schiffer 2006	29285
addition	29304
we	29314
the antibody TUJ-1	29322
Covance , known to be highly reactive to neuron specific class III b-tubulin -LRB- bIII -RRB-	29346
Covance	29346
neuron specific class III b-tubulin	29386
neuron specific class	29386
III b-tubulin	29408
bIII	29423
b-tubulin found in glial cells	29466
b-tubulin	29466
glial cells	29485
our hands	29510
a proportion of both OECs and SCs	29520
a proportion	29520
both OECs and SCs	29536
this marker	29576
these cell cultures	29592
96 % pure -LRB- p75NTR positive -RRB-	29622
96 % pure	29622
96 %	29622
pure	29626
p75NTR	29632
50 % of cells in each case	29659
50 %	29659
cells in each case	29666
cells	29666
each case	29675
TUJ-1 positive	29690
TUJ-1	29690
this	29706
TUJ-1	29724
both OECs and SCs	29746
This	29765
reports	29795
TUJ-1	29808
neurons	29833
a component of the mitotic spindle in multiple cell types	29848
a component	29848
the mitotic spindle in multiple cell types	29863
the mitotic spindle	29863
multiple cell types	29886
human SFs and certain cancer cells -LRB- Jouhilahti et al. , 2008 -RRB-	29917
human SFs	29917
certain cancer cells -LRB- Jouhilahti et al. , 2008 -RRB-	29931
certain cancer cells	29931
Jouhilahti	29953
et al. , 2008	29964
et al.	29964
2008	29972
Both SCs and OECs	29979
high levels of fibronectin	30007
high levels	30007
fibronectin	30022
The fibroblast-like cells from peripheral nerve , olfactory bulb and skin	30035
The fibroblast-like cells	30035
peripheral nerve , olfactory bulb and skin	30066
peripheral nerve	30066
olfactory bulb	30084
skin	30103
markers typical of connective tissue , including SMA , thy1 .1 and fibronectin	30118
markers	30118
connective tissue	30137
SMA , thy1 .1 and fibronectin	30166
SMA	30166
thy1 .1	30171
fibronectin	30182
the cells obtained from these tissues	30204
the cells	30204
these tissues	30228
one another	30276
the percentage of cells expressing the various antigens	30289
the percentage	30289
cells expressing the various antigens	30307
cells	30307
the various antigens	30324
Cells isolated from the skin	30355
Cells	30355
the skin	30375
a positive control for typical fibroblasts	30397
a positive control	30397
typical fibroblasts	30420
These cells	30441
fibronectin -LRB- 100 % -RRB- and high levels of thy1 .1 -LRB- 75 % -RRB- and TUJ-1 -LRB- 59 % -RRB-	30463
fibronectin	30463
100 %	30476
high levels of thy1 .1 -LRB- 75 % -RRB- and TUJ-1 -LRB- 59 % -RRB-	30486
high levels	30486
thy1 .1 -LRB- 75 % -RRB- and TUJ-1 -LRB- 59 % -RRB-	30501
thy1 .1	30501
75 %	30509
TUJ-1	30518
59 %	30525
A proportion of these cells -LRB- 36 % -RRB-	30531
A proportion	30531
these cells -LRB- 36 % -RRB-	30547
these cells	30547
36 %	30560
SMA	30580
3 %	30593
nestin	30606
PNFBs	30614
a similar antigenic profile to SFs but with some quantitative differences	30624
a similar antigenic profile	30624
SFs	30655
some quantitative differences	30668
contrast	30702
the fibroblast-like cells isolated from the olfactory bulb	30712
the fibroblast-like cells	30712
the olfactory bulb	30752
a dramatically different antigenic profile	30778
particular a higher proportion of cells expressed nestin -LRB- 77 % -RRB- and SMA -LRB- 66 % -RRB- and many fewer expressed Thy1 .1 -LRB- 4 % -RRB-	30825
particular a higher proportion	30825
cells expressed nestin -LRB- 77 % -RRB- and SMA -LRB- 66 % -RRB- and many fewer expressed Thy1 .1	30859
cells	30859
nestin -LRB- 77 % -RRB- and SMA -LRB- 66 % -RRB- and many fewer expressed Thy1 .1	30875
nestin -LRB- 77 % -RRB- and SMA -LRB- 66 % -RRB-	30875
nestin -LRB- 77 % -RRB-	30875
nestin	30875
77 %	30883
SMA -LRB- 66 % -RRB-	30892
SMA	30892
66 %	30897
many fewer expressed Thy1 .1	30906
many fewer	30906
Thy1 .1	30927
4 %	30935
These data	30940
these cells	30959
typical fibroblasts	30979
Cultures generated from the olfactory mucosa	31000
Cultures	31000
the olfactory mucosa	31024
a mixed population of cells	31055
a mixed population	31055
cells	31077
the connective tissue of the lamina propria as well as OECs -LRB- 12 % ; Toft et al. , 2012 -RRB-	31088
the connective tissue	31088
the lamina propria as well as OECs	31113
the lamina propria	31113
OECs	31143
12 %	31149
Toft et al. , 2012	31154
Toft	31154
et al.	31159
2012	31167
It	31174
10 days in culture	31200
10 days	31200
culture	31211
any neurons	31219
some olfactory epithelial cells	31255
the culture	31303
the 3 % of nuclei not labeled with any of the panel of antibodies -LRB- Schwob et al. , 2002 -RRB-	31337
the 3 %	31337
nuclei not labeled with any of the panel of antibodies	31347
nuclei	31347
any of the panel of antibodies	31371
any	31371
the panel of antibodies	31378
the panel	31378
antibodies	31391
Schwob	31403
et al. , 2002	31410
et al.	31410
2002	31418
Density of Axonal Regeneration	31425
Density	31425
Axonal Regeneration	31436
Different Transplants Regeneration of spinal cord axons into transplants of each cell type	31463
Different Transplants Regeneration	31463
spinal cord axons into transplants of each cell type	31501
spinal cord axons	31501
transplants of each cell type	31524
transplants	31524
each cell type	31539
6 weeks	31575
the density of neurofilament positive axons	31598
the density	31598
neurofilament positive axons	31613
confocal image stacks obtained from the transplant sites	31645
confocal image stacks	31645
the transplant sites	31681
Figure 2A -- G shows confocal microscope images of typical sections through dorsal column lesions transplanted with the different cell types and immunolabeled with the axonal marker neurofilament-200 -LRB- shown in red -RRB- .	31703
Figure 2A	31703
G shows confocal microscope images of typical sections through dorsal column lesions transplanted with the different cell types and immunolabeled with the axonal marker neurofilament-200 -LRB- shown in red -RRB-	31713
G shows	31713
confocal microscope images of typical sections through dorsal column lesions transplanted with the different cell types and immunolabeled with the axonal marker neurofilament-200 -LRB- shown in red -RRB-	31721
confocal microscope images of typical sections through dorsal column lesions transplanted with the different cell types and immunolabeled with the axonal marker neurofilament-200	31721
confocal microscope images	31721
typical sections through dorsal column lesions transplanted with the different cell types and immunolabeled with the axonal marker neurofilament-200	31751
typical sections	31751
dorsal column lesions transplanted with the different cell types and immunolabeled with the axonal marker neurofilament-200	31776
dorsal column lesions	31776
the different cell types	31816
the axonal marker neurofilament-200	31864
Neurofilament positive fibers could be seen entering and growing within transplants of all of the cell types	31916
Neurofilament	31916
positive fibers	31930
transplants of all of the cell types	31988
transplants	31988
all of the cell types	32003
all	32003
the cell types	32010
each	32051
axonal regeneration	32065
some degree	32088
the density of axonal regeneration	32110
the density	32110
axonal regeneration	32125
the transplants	32160
the quantitative analysis in Figure 2H	32193
the quantitative analysis	32193
Figure 2H	32222
Transplants of OECs	32233
Transplants	32233
OECs	32248
the greatest axonal density and therefore regeneration	32263
the greatest axonal density	32263
regeneration	32305
transplants of SCs and even PNFBs and SFs , not generally considered as cell types supporting axonal regeneration ,	32322
transplants	32322
SCs and even PNFBs and SFs	32337
SCs	32337
even PNFBs and SFs	32345
cell types supporting axonal regeneration	32393
cell types	32393
axonal regeneration	32415
substantial numbers of axons	32446
substantial numbers	32446
axons	32469
OBFB-like cells	32476
significantly fewer regenerating axons	32502
all other cell types tested	32546
all other cell types	32546
OECs	32580
the OBFB-L cells	32601
regeneration	32619
the cell mixture	32650
OECs	32697
Extent of Axonal Regeneration Supported by Different Transplants To determine if in-growing axons detected within the transplants regenerated beyond the lesion , tract tracing studies	32709
Extent	32709
Axonal Regeneration Supported by Different Transplants To determine if in-growing axons detected within the transplants regenerated beyond the lesion , tract tracing studies	32719
Axonal Regeneration	32719
Different Transplants	32752
in-growing axons detected within the transplants	32790
in-growing axons	32790
the transplants	32823
the lesion , tract tracing studies	32858
the lesion	32858
tract tracing studies	32870
tract	32870
studies	32884
a subset of animals	32910
a subset	32910
animals	32922
these experiments	32934
BDA	32953
the L4 and L5 spinal nerves	32975
the L4	32975
L5 spinal nerves	32986
dorsal column fibers	33022
Examples of BDA labeled fibers in animals transplanted with OECs , SCs , PNFB and OM	33044
Examples	33044
BDA labeled fibers in animals transplanted with OECs , SCs , PNFB and OM	33056
BDA	33056
fibers	33068
animals transplanted with OECs , SCs , PNFB and OM	33078
animals	33078
OECs , SCs , PNFB and OM	33104
Figure 3	33140
dorsal column fibers	33172
all cell types tested , showing that primary afferent fibers are among those regenerating in the transplants	33207
all cell types	33207
primary afferent fibers	33243
those regenerating in the transplants	33277
those	33277
the transplants	33299
axons	33316
the transplanted lesion in any of the animals	33344
the transplanted lesion	33344
any of the animals	33371
any	33371
the animals	33378
Extent of Glial Scar Wire knife lesioning of the white matter of the dorsal columns	33391
Extent	33391
Glial Scar Wire knife lesioning of the white matter of the dorsal columns	33401
Glial Scar Wire knife lesioning	33401
the white matter of the dorsal columns	33436
the white matter	33436
the dorsal columns	33456
a gap that develops over several weeks into a fluid filled cavity	33483
a gap	33483
several weeks	33508
a fluid filled cavity	33527
a fluid	33527
cavity	33542
the absence of a cell transplant	33553
the absence	33553
a cell transplant	33568
this gap or cavity	33587
time -LRB- Toft et al. , 2007 -RRB-	33635
time	33635
Toft	33641
et al. , 2007	33646
et al.	33646
2007	33654
All of the various cell types	33661
All	33661
the various cell types	33668
the gap created by lesioning	33698
the gap	33698
the development of cavities	33741
the development	33741
cavities	33760
there	33779
a marked difference in the rostro-caudal extent of the lesion site as defined by GFAP immunolabeling of the glial scar	33789
a marked difference	33789
the rostro-caudal extent of the lesion site as defined by GFAP immunolabeling of the glial scar	33812
the rostro-caudal extent	33812
the lesion site as defined by GFAP immunolabeling of the glial scar	33840
the lesion site as	33840
GFAP immunolabeling of the glial scar	33870
GFAP immunolabeling	33870
the glial scar	33893
Confocal microscope images illustrating the typical appearance of GFAP immunolabeling at lesions transplanted with different cell types taken at the same magnification	33909
Confocal microscope images	33909
the typical appearance of GFAP immunolabeling	33949
the typical appearance	33949
GFAP immunolabeling	33975
lesions transplanted with different cell types taken at the same magnification	33998
lesions	33998
different cell types taken at the same magnification	34024
different cell types	34024
the same magnification	34054
Figure 4	34090
the length of the cell-filled injury site	34105
the length	34105
the cell-filled injury site	34119
OECs and SCs	34163
the smallest lesion sites -LRB- ca. 1.2 mm in length at 6 weeks -RRB-	34185
the smallest lesion sites	34185
ca. 1.2 mm in length at 6 weeks	34212
ca.	34212
1.2 mm in length at 6 weeks	34216
1.2 mm	34216
length at 6 weeks	34226
length	34226
6 weeks	34236
transplants containing fibroblasts	34252
transplants	34252
fibroblasts	34275
more extensive lesion environments -LRB- 1.5 -- 2.1 mm -RRB-	34299
more extensive lesion environments	34299
1.5 -- 2.1 mm	34335
1.5	34335
2.1 mm	34339
transplanted OM	34351
the most extensive injury sites -LRB- 2.5 mm rostro-caudally -RRB-	34376
the most extensive injury sites	34376
2.5 mm	34409
Glial Cell Reaction to Transplanted Cells in Non-lesioned Cord To further investigate the reaction of host astrocytes to transplanted cells	34434
Glial Cell Reaction	34434
Cells	34470
Non-lesioned Cord	34479
the reaction of host astrocytes	34520
the reaction	34520
host astrocytes	34536
transplanted cells	34555
small injections of cells	34575
small injections	34575
cells	34595
the normal spinal cord	34616
immunolabeling for GFAP and nestin	34643
immunolabeling	34643
GFAP and nestin	34662
the processes of reactive astrocytes	34692
the processes	34692
reactive astrocytes	34709
tissue sections	34743
the transplant site	34764
10 days	34790
Figure 5 shows typical comparable sections of the injection sites from different animals ,	34799
Figure	34799
5 shows typical comparable sections of the injection sites	34806
5 shows typical comparable sections	34806
5 shows	34806
the injection sites	34845
different animals	34870
nestin -LRB- red -RRB- and GFAP -LRB- blue -RRB-	34908
nestin	34908
red	34916
GFAP	34925
blue	34931
Injection with medium	34938
Injection	34938
medium	34953
a minimal glial reaction	34975
the narrow profile of an injection pipette track	35005
the narrow profile	35005
an injection pipette track	35027
Injection with cells	35055
Injection	35055
cells	35070
a glial reaction , the extent of which varied with cell type	35085
a glial reaction	35085
cell type	35135
Consistent with our previous reports -LRB- Lakatos et al. , 2000 ; Santos-Silva et al. , 2007 -RRB- OECs	35146
our previous reports -LRB- Lakatos et al. , 2000 ; Santos-Silva et al. , 2007 -RRB-	35162
our previous reports	35162
Lakatos	35184
et al. , 2000 ; Santos-Silva et al. , 2007	35192
et al.	35192
2000 ; Santos-Silva et al.	35200
2000	35200
Santos-Silva et al.	35206
Santos-Silva	35206
et al.	35219
2007	35227
relatively low amounts of astrocytic hypertrophy	35247
relatively low amounts	35247
astrocytic hypertrophy	35273
there	35300
clear mingling of astrocytes with the central bolus of injected cells	35310
clear mingling	35310
astrocytes with the central bolus of injected cells	35328
astrocytes	35328
the central bolus of injected cells	35344
the central bolus	35344
injected cells	35365
SCinduced astrocytic hypertrophy	35387
extent	35435
astrocytes	35446
the central cell bolus	35484
There	35508
very little mingling between astrocytes and the PNFB and OM grafts	35523
very little mingling	35523
astrocytes and the PNFB and OM grafts	35552
astrocytes	35552
the PNFB and OM grafts	35567
These cells	35591
a more extensive pattern of hypertrophy	35617
a more extensive pattern	35617
hypertrophy	35645
the central cell bolus	35682
Those cells	35706
larger GFAP immunoreactive injury sites were also associated with the most marked astrocytic response as defined by nestin IR and this was therefore more prominent in the fibroblast-like cell grafts -LRB- Fig. 5J -- R -RRB-	35734
larger GFAP	35734
immunoreactive injury sites	35746
the most marked astrocytic response	35800
nestin IR and this	35850
nestin IR	35850
this	35864
the fibroblast-like cell grafts -LRB- Fig. 5J -- R -RRB-	35901
the fibroblast-like cell grafts	35901
Fig. 5J -- R	35934
Fig. 5J	35934
R	35942
Interaction of	35946
Interaction	35946
Cells	35974
Axons	35998
some transplants	36007
we	36025
the ability of OECs and SCs engineered to express GFP to interact with axons	36037
the ability	36037
OECs and SCs engineered to express GFP to interact with axons	36052
OECs and SCs	36052
GFP	36087
axons	36108
Both cell types	36115
axons	36168
myelination of fibers -LRB- Fig. 6A -- C -RRB- in both cell transplants	36210
myelination	36210
fibers -LRB- Fig. 6A -- C -RRB- in both cell transplants	36225
fibers -LRB- Fig. 6A -- C -RRB-	36225
fibers	36225
Fig. 6A -- C	36233
Fig. 6A	36233
C	36241
both cell transplants	36247
the correct formation of the paranodal protein	36274
the correct formation	36274
the paranodal protein	36299
neurofascin -LRB- Fig. 6E , F -RRB-	36321
neurofascin	36321
Fig. 6E , F	36334
Fig. 6E	36334
F	36342
P0 labeling around nerve fibers	36360
P0	36360
nerve fibers	36379
PNFB transplants	36409
some myelination of regenerating fibers	36442
some myelination	36442
regenerating fibers	36462
transplants of cells which do not have a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36504
transplants	36504
cells which do not have a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36519
cells	36519
a myelinating phenotype -LRB- Fig. 6C , D -RRB-	36543
a myelinating phenotype	36543
Fig. 6C , D	36568
Fig. 6C	36568
D	36576
DISCUSSION Rationale for Cells Included in the Study Cell transplantation	36581
DISCUSSION Rationale	36581
Cells Included in the Study Cell transplantation	36606
Cells	36606
the Study Cell transplantation	36624
a potential means of effecting CNS repair -LRB- Murray and Fischer , 2001 ; Barnett and Riddell 2007 ; Tetzlaff et al. , 2011 -RRB-	36658
a potential means	36658
effecting CNS repair -LRB- Murray and Fischer , 2001 ; Barnett and Riddell 2007 ; Tetzlaff et al. , 2011 -RRB-	36679
effecting CNS repair	36679
Murray and Fischer , 2001 ; Barnett and Riddell 2007 ; Tetzlaff et al. , 2011	36701
Murray and Fischer	36701
2001 ; Barnett and Riddell 2007 ; Tetzlaff et al.	36721
2001	36721
Barnett and Riddell 2007 ; Tetzlaff et al.	36727
Barnett and Riddell 2007	36727
Barnett	36727
Riddell 2007	36739
Tetzlaff et al.	36753
Tetzlaff	36753
et al.	36762
2011	36770
Autologous transplantation of differentiated cell types	36777
Autologous transplantation	36777
cell types	36822
one strategy for sourcing cells	36836
one strategy	36836
sourcing cells	36853
the advantage of avoiding the cell engineering and immunosuppression which may be required for some stem cell sources	36883
the advantage	36883
the cell engineering and immunosuppression which may be required for some stem cell sources	36909
the cell engineering and immunosuppression	36909
some stem cell sources	36978
this investigation	37005
we	37025
the axonal growth	37042
properties of a range of differentiated and characterized neural and non-neural cell types , each of which have been used previously in animal models of spinal cord injury repair but have never been directly compared in the same model	37071
properties	37071
a range of differentiated and characterized neural and non-neural cell types , each of which have been used previously in animal models of spinal cord injury repair but have never been directly compared in the same model	37085
a range	37085
non-neural cell types	37140
each	37163
animal models of spinal cord injury repair	37206
animal models	37206
spinal cord injury repair	37223
the same model	37290
The cells tested	37306
The cells	37306
glial cells -LRB- SCs and OECs -RRB- which are well established to support axonal regeneration	37331
glial cells	37331
SCs and OECs	37344
SCs	37344
OECs	37352
axonal regeneration	37396
These	37417
fibroblastlike cells , some of which are intimately associated with glial cells in situ -LRB- PNFBs in the case of SCs and fibroblast - like cells from olfactory bulb -RRB-	37447
fibroblastlike cells	37447
some	37469
glial cells in situ	37514
glial cells	37514
situ	37529
PNFBs in the case of SCs and fibroblast - like cells from olfactory bulb	37535
PNFBs	37535
the case of SCs and fibroblast	37544
the case	37544
SCs and fibroblast	37556
cells from olfactory bulb	37581
cells	37581
olfactory bulb	37592
most previous studies	37612
these cells	37635
undesirable contaminants of purified glial cell cultures and the culture process employed	37668
undesirable contaminants	37668
purified glial cell cultures and the culture process employed	37696
purified glial cell cultures	37696
the culture process employed	37729
the culture process	37729
their presence -LRB- Barnett and Roskams , 2008 -RRB-	37798
their presence	37798
Barnett and Roskams	37814
2008	37835
This methodology	37842
the assumption	37874
glial cells	37894
properties that will optimize regeneration	37911
properties	37911
regeneration	37941
transplants of purified glial cells	37963
transplants	37963
purified glial cells	37978
regeneration	38012
fibroblast-like cells	38050
this	38095
views	38145
example	38176
one group	38185
cell preparations that include a mixture of olfactory bulb OECs and fibroblastlike cells	38207
cell preparations	38207
a mixture of olfactory bulb OECs and fibroblastlike cells	38238
a mixture	38238
olfactory bulb OECs and fibroblastlike cells	38251
olfactory bulb OECs	38251
fibroblastlike cells	38275
optimal reparative properties for promoting axonal regeneration -LRB- Raisman and Li , 2007 -RRB-	38301
optimal reparative properties	38301
axonal regeneration -LRB- Raisman and Li , 2007 -RRB-	38345
axonal regeneration	38345
Raisman and Li , 2007	38366
Raisman	38366
Li , 2007	38378
Li	38378
2007	38382
addition	38392
some groups	38402
nondissociated tissue	38440
cells	38483
example	38494
olfactory lamina propria	38503
some rat studies	38553
these	38574
the basis for clinical trials involving autologous transplantation of these tissues in spinal cord injured patients -LRB- Lima et al. , 2010 ; Mackay - Sim and St John. , 2011 -RRB-	38590
the basis	38590
clinical trials involving autologous transplantation of these tissues in spinal cord injured patients -LRB- Lima et al. , 2010 ; Mackay - Sim and St John. , 2011 -RRB-	38604
clinical trials	38604
autologous transplantation of these tissues in spinal cord injured patients -LRB- Lima et al. , 2010 ; Mackay - Sim and St John. , 2011 -RRB-	38630
autologous transplantation	38630
these tissues in spinal cord injured patients -LRB- Lima et al. , 2010 ; Mackay - Sim and St John. , 2011 -RRB-	38660
these tissues in spinal cord injured patients	38660
these tissues in spinal cord	38660
these tissues	38660
spinal cord	38677
Lima et al. , 2010 ; Mackay - Sim and St John. , 2011	38707
Lima	38707
et al. , 2010 ; Mackay - Sim and St John. , 2011	38712
et al.	38712
2010	38720
Mackay	38726
Sim	38734
St John. , 2011	38742
St John.	38742
2011	38752
These	38759
complex tissues containing many diverse cell types -LRB- Lindsay et al. , 2010 -RRB-	38769
complex tissues	38769
many diverse cell types -LRB- Lindsay et al. , 2010 -RRB-	38796
many diverse cell types	38796
Lindsay	38821
et al. , 2010	38829
et al.	38829
2010	38837
there	38847
contamination	38875
cells from the adjacent olfactory epithelium	38894
cells	38894
the adjacent olfactory epithelium	38905
the effect these cells	38949
the effect	38949
these cells	38960
transplanted into the spinal cord	38986
transplanted	38986
the spinal cord	39004
this study	39052
we	39064
some of these issues	39084
some	39084
these issues	39092
key properties of different cells	39118
key properties	39118
different cells	39136
identical conditions	39176
Axonal regeneration	39198
We	39218
the ability of the cell transplants	39244
the ability	39244
the cell transplants	39259
axonal regeneration	39291
We	39312
this	39319
the density of axons	39339
the density	39339
axons	39354
the cells transplanted into the gap created by a wire-knife injury	39367
the cells	39367
the gap created by a wire-knife injury	39395
the gap	39395
a wire-knife injury	39414
these axons	39443
regenerating axons	39490
We	39510
the transplants	39527
the injury because we wished to focus on the intrinsic growth support that the cells provide directly to growing axons	39565
the injury	39565
we	39584
the intrinsic growth support	39606
the cells	39640
growing axons	39670
the complication that different cell types might modify the glial scar at the transplant-host interface in different ways -LRB- see below -RRB-	39693
the complication	39693
different cell types	39715
the glial scar	39749
the transplant-host interface in different ways	39767
the transplant-host interface	39767
different ways	39800
the number of fibers able to enter the graft	39851
the number	39851
fibers able to enter the graft	39865
fibers	39865
the graft	39886
we	39923
axons	39940
the transplant	39966
the glial scar	39988
the effects of interactions between transplanted and host cells as a factor affecting the numbers of axons within the graft	40031
the effects	40031
interactions between transplanted and host cells as a factor affecting the numbers of axons within the graft	40046
interactions	40046
transplanted and host cells as a factor affecting the numbers of axons within the graft	40067
transplanted and host cells	40067
a factor affecting the numbers of axons within the graft	40098
a factor	40098
the numbers of axons within the graft	40117
the numbers	40117
axons within the graft	40132
axons	40132
the graft	40145
A notable finding of the current investigation	40156
A notable finding	40156
the current investigation	40177
all of the cell types and cell mixtures tested	40211
all	40211
the cell types and cell mixtures tested	40218
the cell types and cell mixtures	40218
some degree of axonal regeneration	40266
some degree	40266
axonal regeneration	40281
the presence of numerous neurofilament	40318
the presence	40318
numerous neurofilament	40334
immunolabeled fibers distributed amongst the transplanted cells	40357
immunolabeled fibers	40357
the transplanted cells	40398
OECs versus SCs	40422
all cell transplants tested	40447
all cell transplants	40447
axonal regeneration , purified populations of glial cells	40486
axonal regeneration	40486
populations of glial cells	40516
populations	40516
glial cells	40531
the highest density of axons	40556
the highest density	40556
axons	40579
transplants	40592
OECs tending to support a higher density than SCs , though this difference was not significant	40610
OECs	40610
a higher density	40634
SCs	40656
this difference	40668
The reparative potential of both OECs and SCs	40705
The reparative potential	40705
both OECs and SCs	40733
detail	40771
it	40788
both cell types	40816
axonal regeneration	40840
there	40861
surprisingly few direct comparisons	40877
the same experimental conditions	40919
Takami et al. -LRB- 2002 -RRB-	40953
Takami et al.	40953
Takami	40953
et al.	40960
2002	40968
SCs	40983
OECs	41000
the olfactory bulb in a moderate contusion injury in which transplants were performed after 1 week	41010
the olfactory bulb	41010
a moderate contusion injury in which transplants were performed after 1 week	41032
a moderate contusion injury	41032
transplants	41069
1	41102
week	41104
Estimations of the numbers of myelinated axons within the transplant	41110
Estimations	41110
the numbers of myelinated axons within the transplant	41125
the numbers	41125
myelinated axons within the transplant	41140
myelinated axons	41140
the transplant	41164
toluidine blue semithin sections	41195
the injury / transplant site	41233
the injury	41233
transplant site	41245
Both SC and OEC transplant sites	41262
more than twice	41305
many fibers	41324
nontransplanted controls	41339
SC transplants supporting more than OEC transplants	41370
SC transplants	41370
more	41396
OEC transplants	41406
a contusion injury	41435
it	41454
sparing and regeneration of fibers at the injury site	41496
sparing and regeneration	41496
fibers at the injury site	41524
fibers	41524
the injury site	41534
a subsequent study in the same model using transplantation at the same 1 week time point -LRB- Pearse et al. , 2007 -RRB-	41564
a subsequent study	41564
the same model using transplantation at the same 1 week time point -LRB- Pearse et al. , 2007 -RRB-	41586
the same model	41586
transplantation	41607
the same 1 week time point -LRB- Pearse et al. , 2007 -RRB-	41626
the same 1 week time point	41626
Pearse	41654
et al. , 2007	41661
et al.	41661
2007	41669
OEC survival	41687
that of SCs	41721
that	41721
SCs	41729
4 % of transplanted cells remaining 3 weeks post-transplantation	41744
4 %	41744
transplanted cells remaining 3 weeks post-transplantation	41750
transplanted cells	41750
3 weeks	41779
differences in cell survival	41817
differences	41817
cell survival	41832
the comparison of regeneration	41866
the comparison	41866
regeneration	41884
this model	41909
the only other direct comparison carried out to our knowledge , SCs and a 50:50 OEC/fibroblast - like cell mixture prepared from Fischer	41924
the only other direct comparison	41924
our knowledge , SCs and a 50:50 OEC/fibroblast	41972
our knowledge	41972
SCs	41987
a 50:50 OEC/fibroblast	41995
cell mixture prepared from Fischer	42024
cell mixture	42024
Fischer	42051
rats	42059
a dorsal column crush model in immunosuppressed Sprague-Dawley rats	42087
a dorsal column crush model	42087
immunosuppressed Sprague-Dawley rats	42118
Both transplants	42156
similar numbers of GAP-43 positive immunolabeling	42194
similar numbers	42194
GAP-43 positive immunolabeling	42213
Many of these profiles	42245
Many	42245
these profiles	42253
co-localized neurofilament though these were not quantified	42268
co-localized neurofilament	42268
these	42302
Andrews and Stelzner	42329
2007	42351
this very limited information and some of the technical complications involved in previous studies	42364
this very limited information	42364
some of the technical complications involved in previous studies	42398
some	42398
the technical complications involved in previous studies	42406
the technical complications	42406
previous studies	42446
our findings	42464
the clearest indication	42485
transplants of OECs from the olfactory bulb support axonal regeneration at least	42518
transplants	42518
OECs from the olfactory bulb support axonal regeneration at least	42533
OECs	42533
the olfactory bulb support axonal regeneration at least	42543
the olfactory bulb support axonal regeneration	42543
SC transplants	42650
OECs versus OEC and fibroblast-like cell mixtures	42675
OECs	42675
OEC and fibroblast-like cell mixtures	42687
Most groups studying OECs	42725
Most groups	42725
OECs	42746
some form of purification step in their culture procedures	42758
some form	42758
purification step in their culture procedures	42771
purification step	42771
their culture procedures	42792
highly enriched cultures of OECs -LRB- Barnett and Roskams , 2008 -RRB-	42851
highly enriched cultures	42851
OECs -LRB- Barnett and Roskams , 2008 -RRB-	42879
OECs	42879
Barnett and Roskams	42885
2008	42906
one group -LRB- Li et al. , 2003 -RRB- routinely transplant mixtures of OECs -LRB- approximately 50 % of cells -RRB- together with fibroblast like cells from the olfactory bulb	42922
one group -LRB- Li et al. , 2003 -RRB-	42922
Li	42933
et al. , 2003	42936
et al.	42936
2003	42944
transplant mixtures of OECs -LRB- approximately 50 % of cells -RRB-	42960
transplant mixtures	42960
OECs -LRB- approximately 50 % of cells -RRB-	42983
OECs	42983
approximately 50 % of cells	42989
approximately 50 %	42989
cells	43010
fibroblast	43031
cells from the olfactory bulb	43047
cells	43047
the olfactory bulb	43058
OECs and the fibroblastlike cells	43078
OECs	43078
the fibroblastlike cells	43087
growing axons of olfactory receptor neurons towards the olfactory bulb -LRB- Li et al. , 2005a , b -RRB-	43142
growing axons	43142
olfactory receptor neurons towards the olfactory bulb -LRB- Li et al. , 2005a , b -RRB-	43159
olfactory receptor neurons	43159
the olfactory bulb -LRB- Li et al. , 2005a , b -RRB-	43194
the olfactory bulb	43194
Li	43214
et al. , 2005a , b	43217
et al.	43217
2005a	43225
b	43231
it	43238
these cells	43275
a pathway along which regenerating fibers can extend -LRB- Raisman and Li , 2007 -RRB-	43292
a pathway	43292
regenerating fibers	43314
Raisman and Li , 2007	43346
Raisman	43346
Li , 2007	43358
Li	43358
2007	43362
This group	43369
the collaboration of both cells types	43403
the collaboration	43403
both cells types	43424
successful axonal regeneration	43457
corticospinal fibers	43492
the transplanted lesion	43521
Other groups	43546
report that corticospinal fibers	43569
report	43569
corticospinal fibers	43581
transplants of olfactory bulb OECs -LRB- Ruitenberg et al. , 2005 -RRB- or lamina propria OECs -LRB- Lu et al. , 2006 -RRB-	43637
transplants	43637
olfactory bulb OECs -LRB- Ruitenberg et al. , 2005 -RRB- or lamina propria OECs -LRB- Lu et al. , 2006 -RRB-	43652
olfactory bulb OECs	43652
Ruitenberg	43673
et al. , 2005	43684
et al.	43684
2005	43692
lamina propria OECs	43701
Lu	43722
et al. , 2006	43725
et al.	43725
2006	43733
We	43740
regeneration of ascending dorsal column fibers after transplantation of purified OECs and cell mixtures obtained from the olfactory bulb but while both supported regeneration within the transplant	43772
regeneration	43772
dorsal column fibers after transplantation of purified OECs and cell mixtures obtained from the olfactory bulb but while both supported regeneration within the transplant	43798
dorsal column fibers	43798
transplantation of purified OECs and cell mixtures	43825
transplantation	43825
purified OECs and cell mixtures	43844
the olfactory bulb	43890
both	43919
regeneration	43934
the transplant	43954
regeneration	43987
the graft -LRB- Toft et al. , 2007 -RRB-	44007
the graft	44007
Toft	44018
et al. , 2007	44023
et al.	44023
2007	44031
the current study	44041
we	44059
the density of axonal regeneration	44076
the density	44076
axonal regeneration	44091
transplants of purified OECs	44118
transplants	44118
purified OECs	44133
transplants of the cells which the Raisman group include in their `` OEC transplants '' and in a 50:50 mixture of OECs with the fibroblast-like cells	44155
transplants	44155
the cells which the Raisman group include in their `` OEC transplants '' and in a 50:50 mixture of OECs with the fibroblast-like cells	44170
the cells	44170
the Raisman group	44186
their `` OEC transplants ''	44215
a 50:50 mixture of OECs with the fibroblast-like cells	44248
a 50:50 mixture	44248
OECs with the fibroblast-like cells	44267
OECs	44267
the fibroblast-like cells	44277
Our findings	44304
purified OECs	44327
the most axonal growth	44349
fibroblast-like cells	44381
significantly less regeneration	44417
OECs	44457
the fibroblast	44465
cells	44485
support	44500
axonal regeneration	44512
the same extent as OECs	44543
the same extent	44543
OECs	44562
regeneration within the cell mixture	44581
regeneration	44581
the cell mixture	44601
that within transplants of purified OECs	44650
that	44650
transplants of purified OECs	44662
transplants	44662
purified OECs	44677
This	44692
support for axonal regeneration	44711
support	44711
axonal regeneration	44723
purification of OECs obtained from the olfactory bulb	44759
purification	44759
OECs obtained from the olfactory bulb	44775
OECs	44775
the olfactory bulb	44794
Reasons for the variation in findings between different groups	44814
Reasons	44814
the variation in findings between different groups	44826
the variation	44826
findings between different groups	44843
findings	44843
different groups	44860
Several studies	44892
the age of OECs in culture	44924
the age	44924
OECs in culture	44935
OECs	44935
culture	44943
a factor which may influence their pro-regenerative properties -LRB- Franssen et al. , 2008 ; Llamus ı et al. , 2011 -RRB-	44954
a factor	44954
their pro-regenerative properties	44983
Franssen	45018
et al. , 2008 ; Llamus ı et al. , 2011	45027
et al.	45027
2008 ; Llamus ı et al.	45035
2008	45035
Llamus ı et al.	45041
Llamus ı	45041
et al.	45050
2011	45058
a recent in vivo study	45068
recent	45070
this idea , at least for certain nerve fiber types -LRB- Novikova et al. , 2011 -RRB-	45100
this idea , at least	45100
this idea	45100
certain nerve fiber types	45124
Novikova	45151
et al. , 2011	45160
et al.	45160
2011	45168
the use of neonatal compared with adult animals as a cell source , culturing of OECs and fibroblast-like cells together rather than as separate pure populations , and differences in the methods used to assess axonal regeneration	45184
the use	45184
neonatal compared with adult animals as a cell source , culturing of OECs and fibroblast-like cells together rather than as separate pure populations , and differences in the methods used to assess axonal regeneration	45195
neonatal compared with adult animals as a cell source , culturing of OECs and fibroblast-like cells together rather than as separate pure populations	45195
neonatal	45195
adult animals as a cell source , culturing of OECs and fibroblast-like cells together rather than as separate pure populations	45218
adult animals	45218
a cell source , culturing of OECs and fibroblast-like cells	45235
a cell source	45235
culturing of OECs and fibroblast-like cells	45250
culturing	45250
OECs and fibroblast-like cells	45263
OECs	45263
fibroblast-like cells	45272
separate pure populations	45318
differences in the methods used to assess axonal regeneration	45349
differences	45349
the methods used to assess axonal regeneration	45364
the methods	45364
axonal regeneration	45391
all potential alternative explanations	45415
The olfactory bulb fibroblast-like cells , when transplanted alone ,	45455
The olfactory bulb fibroblast-like cells	45455
less axonal regeneration	45532
any of the other cell types investigated	45562
any	45562
the other cell types investigated	45569
the other cell types	45569
There	45604
reports	45623
other fibroblast-like cells associated with the nervous system	45636
other fibroblast-like cells	45636
the nervous system	45680
CNS repair	45711
Meningeal fibroblasts	45741
axonal preservation/regeneration	45787
a crush injury	45826
the spinal cord -LRB- Franzen et al. , 1999 -RRB- and regeneration of nigrostriatal dopaminergic axons -LRB- Teng et al. , 2008 -RRB-	45844
the spinal cord -LRB- Franzen et al. , 1999 -RRB-	45844
the spinal cord	45844
Franzen	45861
et al. , 1999	45869
et al.	45869
1999	45877
regeneration of nigrostriatal dopaminergic axons -LRB- Teng et al. , 2008 -RRB-	45887
regeneration	45887
nigrostriatal dopaminergic axons -LRB- Teng et al. , 2008 -RRB-	45903
nigrostriatal dopaminergic axons	45903
Teng	45937
et al. , 2008	45942
et al.	45942
2008	45950
they	45960
the remyelination of experimentally demyelinated spinal axons when co-transplanted with OECs -LRB- Lakatos et al. , 2003 -RRB-	45982
the remyelination	45982
spinal axons	46031
OECs -LRB- Lakatos et al. , 2003 -RRB-	46070
OECs	46070
Lakatos	46076
et al. , 2003	46084
et al.	46084
2003	46092
there	46108
abundant evidence that meningeal-fibroblasts are important components of the glial scar that forms in the injured CNS and that these cells are a source of multiple molecular inhibitors of axonal regeneration -LRB- Shearer and Fawcett , 2001 ; Shearer et al. , 2001 ; Kawano et al. , 2012 -RRB-	46122
abundant evidence	46122
meningeal-fibroblasts	46145
important components of the glial scar that forms in the injured CNS	46171
important components	46171
the glial scar that forms in the injured CNS	46195
the glial scar	46195
the injured CNS	46224
these cells	46249
a source of multiple molecular inhibitors of axonal regeneration -LRB- Shearer and Fawcett , 2001 ; Shearer et al. , 2001 ; Kawano et al. , 2012 -RRB-	46265
a source	46265
multiple molecular inhibitors of axonal regeneration -LRB- Shearer and Fawcett , 2001 ; Shearer et al. , 2001 ; Kawano et al. , 2012 -RRB-	46277
multiple molecular inhibitors	46277
axonal regeneration -LRB- Shearer and Fawcett , 2001 ; Shearer et al. , 2001 ; Kawano et al. , 2012 -RRB-	46310
axonal regeneration	46310
Shearer and Fawcett , 2001 ; Shearer et al. , 2001 ; Kawano et al. , 2012	46331
Shearer and Fawcett	46331
Shearer	46331
Fawcett	46343
2001 ; Shearer et al.	46352
2001	46352
Shearer et al.	46358
Shearer	46358
et al.	46366
2001 ; Kawano et al. , 2012	46374
2001	46374
Kawano et al. , 2012	46380
Kawano	46380
et al. , 2012	46387
et al.	46387
2012	46395
It	46402
the molecular and cellular environment created by transplanting pure populations of meningeal cells	46422
the molecular and cellular environment	46422
pure populations of meningeal cells	46486
pure populations	46486
meningeal cells	46506
that produced by meningeal cells participating in the glial scar	46535
that	46535
meningeal cells participating in the glial scar	46552
meningeal cells	46552
the glial scar	46585
our observations	46605
the OB fibroblast-like cells at least	46635
the OB fibroblast-like cells	46635
more limited axonal regeneration	46682
other cell types	46720
Olfactory mucosa	46738
addition to the olfactory bulb	46758
addition	46758
the olfactory bulb	46770
the olfactory mucosa	46790
OECs	46820
the lamina propria	46832
The OECs from these two sources	46852
The OECs	46852
these two sources	46866
similar , properties -LRB- Ramer et al. , 2004 ; Richter et al. , 2005 ; Lu et al. , 2006 -RRB-	46907
similar	46907
properties -LRB- Ramer et al. , 2004 ; Richter et al. , 2005 ; Lu et al. , 2006 -RRB-	46916
properties	46916
Ramer et al. , 2004 ; Richter et al. , 2005 ; Lu et al. , 2006	46928
Ramer	46928
et al. , 2004 ; Richter et al. , 2005 ; Lu et al. , 2006	46934
et al. , 2004	46934
et al.	46934
2004	46942
Richter et al. , 2005	46948
Richter	46948
et al. , 2005	46956
et al.	46956
2005	46964
Lu et al. , 2006	46970
Lu	46970
et al. , 2006	46973
et al.	46973
2006	46981
their in vivo properties	46997
their	46997
vivo properties	47006
Ramer et al. , 2004	47041
Ramer	47041
et al.	47047
2004	47055
recent transcriptional profiling	47065
notable molecular differences between OB and OM OECs -LRB- Guerout et al. , 2010 -RRB- and even	47108
notable molecular differences between OB and OM OECs -LRB- Guerout et al. , 2010 -RRB-	47108
notable molecular differences	47108
OB and OM OECs	47146
Guerout	47162
et al. , 2010	47170
et al.	47170
2010	47178
subpopulations of cells from the OB -LRB- Honore et al. , 2012 -RRB-	47201
subpopulations	47201
cells from the OB -LRB- Honore et al. , 2012 -RRB-	47219
cells	47219
the OB -LRB- Honore et al. , 2012 -RRB-	47230
the OB	47230
Honore	47238
et al. , 2012	47245
et al.	47245
2012	47253
The functional significance of these differences and their implications for use of these cells in neural repair	47260
The functional significance of these differences	47260
The functional significance	47260
these differences	47291
their implications for use of these cells in neural repair	47313
their implications	47313
use of these cells in neural repair	47336
use	47336
these cells in neural repair	47343
these cells	47343
neural repair	47358
The accessibility of olfactory mucosa	47414
The accessibility	47414
olfactory mucosa	47435
this tissue	47458
an attractive source of cells for autologous transplantation	47470
an attractive source	47470
cells for autologous transplantation	47494
cells	47494
autologous transplantation	47504
large numbers of purified cells from human biopsies	47545
large numbers	47545
purified cells from human biopsies	47562
purified cells	47562
human biopsies	47582
Choi et al. , 2008 ; Gorrie et al. , 2010	47615
Choi	47615
et al. , 2008 ; Gorrie et al. , 2010	47620
et al. , 2008	47620
et al.	47620
2008	47628
Gorrie et al. , 2010	47634
Gorrie	47634
et al. , 2010	47641
et al.	47641
2010	47649
This	47656
some groups	47669
transplantation of non-dissociated olfactory mucosal tissue	47696
transplantation	47696
non-dissociated olfactory mucosal tissue	47715
this tissue	47766
a diverse range of cell types -LRB- Lindsay et al. , 2010 -RRB-	47787
a diverse range	47787
cell types -LRB- Lindsay et al. , 2010 -RRB-	47806
cell types	47806
Lindsay	47818
et al. , 2010	47826
et al.	47826
2010	47834
the olfactory epithelium	47853
the olfactory mucosa as far as possible	47906
the olfactory mucosa	47906
preparation for transplantation	47953
preparation	47953
transplantation	47969
some adherent cells	47986
These OM tissue transplants	48030
the introduction of many cell types which , with the exception of OECs , have not yet been investigated individually for their effect when transplanted into spinal cord injuries	48078
the introduction	48078
many cell types	48098
the exception of OECs	48126
the exception	48126
OECs	48143
their effect	48197
spinal cord injuries	48233
this incomplete information	48263
autologous transplantation of olfactory mucosa	48292
autologous transplantation	48292
olfactory mucosa	48322
clinical trials -LRB- Lima et al. , 2010 ; Mackay-Sim and St John , 2011 -RRB-	48355
clinical trials	48355
Lima	48372
et al. , 2010 ; Mackay-Sim and St John , 2011	48377
et al.	48377
2010 ; Mackay-Sim and St John	48385
2010	48385
Mackay-Sim and St John	48391
Mackay-Sim	48391
St John	48406
2011	48415
a first attempt at assessing how this diverse population of peripheral cells compares to purified glial cells with respect to support for axonal regeneration	48425
a first attempt	48425
this diverse population of peripheral cells	48458
this diverse population	48458
peripheral cells	48485
glial cells	48523
respect	48540
axonal regeneration	48563
we	48584
transplants of dissociated cells obtained from the whole olfactory mucosa in our comparison	48596
transplants	48596
cells obtained from the whole olfactory mucosa in our comparison	48623
cells	48623
the whole olfactory mucosa in our comparison	48643
the whole olfactory mucosa	48643
our comparison	48673
our results	48704
the OM cell mixture	48726
substantial axonal regeneration , comparable to that of purified SCs and PNFBs	48756
substantial axonal regeneration	48756
that of purified SCs and PNFBs	48803
that	48803
purified SCs and PNFBs	48811
greater detail below	48860
greater detail	48860
OM cells	48882
a very significant adverse tissue response	48904
the transplant site	48950
a response markedly greater than that associated with any other of the cell types tested	48971
a response	48971
that associated with any other of the cell types tested	49004
that	49004
any other of the cell types tested	49025
any other	49025
the cell types tested	49038
the cell types	49038
these cells	49076
axonal regeneration	49100
their failure to integrate within the host spinal cord would appear to limit their suitability for transplant	49121
the host spinal cord would appear to limit their suitability for transplant	49155
the host	49155
spinal cord	49164
their suitability	49198
transplant	49220
repair	49240
Skin and PNFBs Fibroblasts from peripheral tissues	49248
Skin and PNFBs Fibroblasts	49248
peripheral tissues	49280
their ability to support axonal regeneration	49333
axonal regeneration	49358
SFs	49379
a growth supportive scaffold	49411
other regeneration stimulating treatments	49454
neurotrophins	49532
spinal cord injury sites -LRB- e.g. , Murray and Fischer , 2001 ; Jones et al. , 2003 ; Lu and Tuszynski , 2008 -RRB-	49549
spinal cord injury sites	49549
e.g. , Murray and Fischer , 2001 ; Jones et al. , 2003 ; Lu and Tuszynski , 2008	49575
e.g.	49575
Murray	49581
Fischer , 2001 ; Jones et al. , 2003 ; Lu and Tuszynski , 2008	49592
Fischer , 2001	49592
Fischer	49592
2001	49601
Jones et al. , 2003	49607
Jones	49607
et al. , 2003	49613
et al.	49613
2003	49621
Lu and Tuszynski , 2008	49627
Lu and Tuszynski	49627
2008	49645
SFs acutely transplanted	49664
SFs	49664
wire knife lesions of the cervical dorsolateral funiculus support ingrowth of rubrospinal axons	49694
wire knife lesions	49694
the cervical dorsolateral funiculus support ingrowth of rubrospinal axons	49716
the cervical dorsolateral funiculus support ingrowth	49716
rubrospinal axons	49772
dorsal column and CGRP positive fiber to some extent , all of which were enhanced when cells were engineered to produce nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49801
dorsal column and CGRP positive fiber	49801
some extent , all of which were enhanced when cells were engineered to produce nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49842
some extent	49842
cells	49887
nerve growth factor -LRB- Jones et al. , 2003 -RRB-	49920
nerve growth factor	49920
Jones	49941
et al. , 2003	49947
et al.	49947
2003	49955
The same group	49962
SFs	49995
a similar density of regenerating axons to adult rat OECs isolated from the lamina propria and to bone marrow mesenchymal stem cells when transplanted into wire knife lesions of the dorsal columns -LRB- Lu et al. , 2006 -RRB-	50007
a similar density	50007
axons	50041
adult rat OECs isolated from the lamina propria and to bone marrow mesenchymal stem cells when transplanted into wire knife lesions of the dorsal columns -LRB- Lu et al. , 2006 -RRB-	50050
adult rat OECs	50050
the lamina propria	50079
bone marrow	50105
mesenchymal stem cells	50117
wire knife lesions of the dorsal columns -LRB- Lu et al. , 2006 -RRB-	50163
wire knife lesions	50163
the dorsal columns -LRB- Lu et al. , 2006 -RRB-	50185
the dorsal columns	50185
Lu	50205
et al. , 2006	50208
et al.	50208
2006	50216
Our results	50223
previous evidence	50243
SF	50266
axonal regeneration	50281
this cell type	50320
significantly less regeneration	50344
purified populations of OECs obtained from the olfactory bulb	50381
purified populations	50381
OECs obtained from the olfactory bulb	50405
OECs	50405
the olfactory bulb	50424
PNFBs , in contrast ,	50444
PNFBs	50444
contrast	50454
a control cell	50489
various candidate cells studied for transplant mediated repair	50515
various candidate cells	50515
transplant	50551
repair	50571
The use of this cell type for this purpose	50579
The use	50579
this cell type for this purpose	50590
this cell type	50590
this purpose	50609
the assumption	50634
they	50654
a neutral cell type with little or no repair promoting properties -LRB- e.g. , Keyvan-Foualadi and Raisman , 2005 ; Pearse et al. , 2007 -RRB-	50663
a neutral cell type	50663
little or no repair promoting properties -LRB- e.g. , Keyvan-Foualadi and Raisman , 2005 ; Pearse et al. , 2007 -RRB-	50688
little or no repair	50688
properties -LRB- e.g. , Keyvan-Foualadi and Raisman , 2005 ; Pearse et al. , 2007 -RRB-	50718
properties	50718
e.g. , Keyvan-Foualadi and Raisman , 2005 ; Pearse et al. , 2007	50730
e.g.	50730
Keyvan-Foualadi and Raisman , 2005 ; Pearse et al.	50736
Keyvan-Foualadi and Raisman , 2005	50736
Keyvan-Foualadi and Raisman	50736
2005	50765
Pearse et al.	50771
Pearse	50771
et al.	50778
2007	50786
reports in the literature	50796
reports	50796
the literature	50807
this view	50852
example	50867
Keyvan-Fouladi and Raisman -LRB- 2003 , 2005 -RRB-	50876
Keyvan-Fouladi and Raisman	50876
2003	50904
2005	50910
transplants of PNFBs	50925
transplants	50925
PNFBs	50940
mixed olfactory cell transplants	50951
no neurofilament-positive staining or P0 labeling -LRB- a marker for peripheral type myelination -RRB-	51002
no neurofilament-positive staining or P0 labeling	51002
a marker for peripheral type myelination	51053
a marker	51053
peripheral type myelination	51066
the fibroblast	51107
transplants	51127
this	51152
olfactory cells , but not PNFBs	51158
olfactory cells	51158
PNFBs	51183
a partial restoration of reaching movements after electrolytic lesions in the cervical dorsal columns	51198
a partial restoration	51198
movements	51232
electrolytic lesions in the cervical dorsal columns	51248
electrolytic lesions	51248
the cervical dorsal columns	51272
They	51301
PNFBs	51332
pure SC populations prior to transplant	51341
pure SC populations	51341
transplant	51370
the reparative effect of these cells -LRB- Keyvan-Fouladi and Raisman , 2005 -RRB-	51411
the reparative effect	51411
these cells -LRB- Keyvan-Fouladi and Raisman , 2005 -RRB-	51436
these cells	51436
Keyvan-Fouladi and Raisman	51449
2005	51477
One of the most surprising findings of the current study	51484
One	51484
the most surprising findings of the current study	51491
the most surprising findings	51491
the current study	51523
the observation	51555
the density of neurofilament containing axons in transplants of fibroblasts from peripheral nerve in wire knife lesions of the dorsal columns	51576
the density	51576
neurofilament containing axons in transplants of fibroblasts from peripheral nerve in wire knife lesions of the dorsal columns	51591
neurofilament	51591
axons in transplants of fibroblasts	51616
axons	51616
transplants of fibroblasts	51625
transplants	51625
fibroblasts	51640
peripheral nerve in wire knife lesions of the dorsal columns	51657
peripheral nerve	51657
wire knife lesions of the dorsal columns	51677
wire knife lesions	51677
the dorsal columns	51699
that detected after SC transplantation	51737
that	51737
SC transplantation	51757
Origin of regenerating fibers Our results clarify the degree to which there are differences in the intrinsic growth supporting properties of the several cell types and cell mixtures	51777
Origin	51777
fibers Our results clarify the degree to which there are differences in the intrinsic growth supporting properties of the several cell types and cell mixtures	51800
fibers	51800
Our results	51807
the degree to which there are differences in the intrinsic growth supporting properties of the several cell types and cell mixtures	51827
the degree	51827
there	51847
differences in the intrinsic growth supporting properties of the several cell types and cell mixtures	51857
differences	51857
the intrinsic growth supporting properties of the several cell types and cell mixtures	51872
the intrinsic growth	51872
properties of the several cell types and cell mixtures	51904
properties	51904
the several cell types and cell mixtures	51918
axonal regeneration	51989
we	52010
the density of regenerating axons detected by immunolabeling for neurofilament proteins	52024
the density	52024
regenerating axons detected by immunolabeling for neurofilament proteins	52039
regenerating axons	52039
immunolabeling for neurofilament proteins	52070
immunolabeling	52070
neurofilament proteins	52089
the normal spinal cord	52116
these fibers	52140
axons that are myelinated , including axons derived from neurons in the brain and primary afferent axons from the dorsal root ganglia	52166
axons	52166
axons derived from neurons in the brain and primary afferent axons from the dorsal root ganglia	52203
axons	52203
neurons in the brain and primary afferent axons	52222
neurons	52222
the brain and primary afferent axons	52233
the brain	52233
primary afferent axons	52247
the dorsal root ganglia	52275
The latter	52300
the majority of axons in the dorsal columns	52319
the majority	52319
axons in the dorsal columns	52335
axons	52335
the dorsal columns	52344
the main origin of the neurofilament	52378
the main origin	52378
the neurofilament	52397
fibers	52423
the transplants	52437
The experiments where we used tract tracing	52454
The experiments	52454
we	52476
tract tracing	52484
tract	52484
at least a proportion of the axons	52512
at least a proportion	52512
the axons	52537
dorsal root ganglia	52562
neurofilament	52592
some of the fine monoaminergic fibers descending from the brain or in fine peptidergic primary afferent fibers	52624
some	52624
the fine monoaminergic fibers descending from the brain or in fine peptidergic primary afferent fibers	52632
the fine monoaminergic fibers	52632
the brain	52678
fine peptidergic primary afferent fibers	52694
Some of these fiber types	52736
Some	52736
these fiber types	52744
a greater propensity for regeneration -LRB- Hawthorne et al. , 2011 -RRB-	52767
a greater propensity	52767
regeneration -LRB- Hawthorne et al. , 2011 -RRB-	52792
regeneration	52792
Hawthorne	52806
et al. , 2011	52816
et al.	52816
2011	52824
we	52834
all fibers types	52866
a similar way	52899
neurofilament labeled axons	52916
neurofilament	52916
axons	52938
Andrews and Stelzner -LRB- 2007 -RRB- report that SC transplants support regenerating CGRP immunopositive fibers while OEC transplants	52953
Andrews and Stelzner	52953
2007	52975
report	52981
SC transplants	52993
CGRP immunopositive fibers	53029
OEC transplants	53062
the OEC transplants	53095
this case	53118
a 50:50 mixture of OECs and fibroblast-like cells	53133
a 50:50 mixture	53133
OECs and fibroblast-like cells	53152
OECs	53152
fibroblast-like cells	53161
immunosuppressed hosts	53206
it	53237
purified OEC transplants	53257
Pearse et al. -LRB- 2007 -RRB- in contrast	53296
Pearse et al.	53296
Pearse	53296
et al.	53303
2007	53311
contrast	53320
neither SCs nor OECs	53341
SCs	53349
OECs	53357
a moderate contusion injury increase CGRP	53380
positive fibers within the graft-injury site	53422
positive fibers	53422
the graft-injury site	53445
control animals	53481
This issue	53498
facilitation of the sprouting of CGRP containing fibers	53536
facilitation	53536
the sprouting of CGRP containing fibers	53552
the sprouting	53552
CGRP containing fibers	53569
CGRP	53569
fibers	53585
an undesirable property	53599
the majority of these	53630
the majority	53630
these	53646
nociceptive primary afferent fibers	53656
mechanisms of pain	53722
mechanisms	53722
pain	53736
Myelination within the Graft and Recruitment of Nontransplanted CELLS	53742
Myelination	53742
the Graft and Recruitment of Nontransplanted CELLS	53761
the Graft and Recruitment	53761
Nontransplanted CELLS	53790
P0 , a marker of peripheral type myelin and neurofascin , a paranodal protein marker	53818
P0	53818
a marker of peripheral type myelin	53822
a marker	53822
peripheral type myelin	53834
neurofascin , a paranodal protein marker	53861
neurofascin	53861
a paranodal protein marker	53874
we	53902
evidence of myelination	53909
evidence	53909
myelination	53921
transplanted GFP-labeled OECs and SCs	53936
transplanted GFP-labeled OECs	53936
SCs	53970
we	53984
non-GFP labeled P0 IR as well as nodal protein IR not associated with P0 staining	54001
non-GFP labeled P0 IR	54001
non-GFP	54001
P0 IR	54017
nodal protein IR not associated with P0 staining	54034
nodal protein IR	54034
P0 staining	54071
The former	54084
P0 myelination	54109
endogenous SCs invading the graft	54141
endogenous SCs	54141
the graft	54165
the minority of transplanted cells which did not express GFP -LRB- although the infection rate was over 90 % -RRB-	54184
the minority	54184
transplanted cells which did not express GFP -LRB- although the infection rate was over 90 % -RRB-	54200
transplanted cells which did not express GFP	54200
transplanted cells	54200
GFP	54241
the infection rate	54255
90 %	54283
The identification of nodal staining without associated P0 labeling	54289
The identification	54289
nodal staining without associated P0 labeling	54311
nodal staining	54311
associated P0 labeling	54334
myelination	54366
endogenous CNS glial cells	54381
P0 IR , presumably from invading SCs ,	54409
P0 IR	54409
SCs	54441
grafts of PNFB-like cells	54463
grafts	54463
PNFB-like cells	54473
some myelination of regenerating fibers	54506
some myelination	54506
regenerating fibers	54526
transplants of cells with a nonmyelinating phenotype	54564
transplants	54564
cells with a nonmyelinating phenotype	54579
cells	54579
a nonmyelinating phenotype	54590
This	54618
the issue of to what extent host cell types that infiltrate the graft site influence the outcome of transplants with different cell types	54630
the issue	54630
extent host cell types that infiltrate the graft site	54651
extent host cell types	54651
the graft site	54690
the outcome of transplants with different cell types	54715
the outcome	54715
transplants with different cell types	54730
transplants	54730
different cell types	54747
It	54769
SCs	54797
OEC transplants	54821
these	54846
peripheral derivation	54859
a response of oligodendrocyte precursor cells	54894
a response	54894
oligodendrocyte precursor cells	54908
injury -LRB- Zawadzka et al. , 2010 -RRB-	54943
injury	54943
Zawadzka	54951
et al. , 2010	54960
et al.	54960
2010	54968
an issue that remains to be clarified	54978
an issue	54978
It	55017
SCs	55049
an important role in the regeneration supported by OECs -LRB- Richter et al. , 2005 -RRB-	55058
an important role	55058
the regeneration supported by OECs -LRB- Richter et al. , 2005 -RRB-	55079
the regeneration	55079
OECs -LRB- Richter et al. , 2005 -RRB-	55109
OECs	55109
Richter	55115
et al. , 2005	55123
et al.	55123
2005	55131
it	55141
host cells recruited by the transplant	55166
host cells	55166
the transplant	55190
other properties such as the host	55229
other properties	55229
the host	55254
graft interaction	55263
Integration of Graft into the Host Tissue	55282
Integration	55282
Graft into the Host Tissue	55297
Graft	55297
the Host Tissue	55308
addition to supporting axonal regeneration , a further important factor determining the suitability of cells for spinal cord repair	55327
addition	55327
axonal regeneration , a further important factor	55350
axonal regeneration	55350
a further important factor	55371
the suitability of cells for spinal cord repair	55410
the suitability	55410
cells for spinal cord repair	55429
cells	55429
spinal cord repair	55439
their readiness to integrate within the host tissues	55465
the host tissues	55501
the current study	55522
we	55541
the ability of various cell types	55553
the ability	55553
various cell types	55568
the host spinal cord using two methods	55607
the host spinal cord	55607
two methods	55634
we	55654
the extent of the glial scar associated with the transplanted dorsal column injury site	55666
the extent	55666
the glial scar associated with the transplanted dorsal column injury site	55680
the glial scar	55680
the transplanted dorsal column injury site	55711
we	55768
the reaction of host astrocytes to the transplanted cells	55780
the reaction	55780
host astrocytes to the transplanted cells	55796
host astrocytes	55796
the transplanted cells	55815
the complication of the response	55846
the complication	55846
the response	55866
injury	55882
injection of a small volume of cells	55893
injection	55893
a small volume of cells	55906
a small volume	55906
cells	55924
the normal spinal cord -LRB- Toft et al. , 2012 ; Santos-Silva et al. , 2007 -RRB-	55935
the normal spinal cord	55935
Toft	55959
et al. , 2012 ; Santos-Silva et al. , 2007	55964
et al.	55964
2012 ; Santos-Silva et al.	55972
2012	55972
Santos-Silva et al.	55978
Santos-Silva	55978
et al.	55991
2007	55999
both approaches	56010
astrocytic hypertrophy	56027
intermediate filament proteins -LRB- GFAP and nestin -RRB- , which are upregulated in reactive astrocytes -LRB- Frisen et al. , 1995 ; Ridet et al. , 1997 -RRB-	56078
intermediate filament proteins -LRB- GFAP and nestin -RRB-	56078
intermediate filament proteins	56078
GFAP and nestin	56110
GFAP	56110
nestin	56119
reactive astrocytes -LRB- Frisen et al. , 1995 ; Ridet et al. , 1997 -RRB-	56153
reactive astrocytes	56153
Frisen	56174
et al. , 1995 ; Ridet et al. , 1997	56181
et al.	56181
1995 ; Ridet et al.	56189
1995	56189
Ridet et al.	56195
Ridet	56195
et al.	56201
1997	56209
These complimentary approaches	56216
results that are in close agreement and indicate marked differences	56256
results	56256
close agreement	56276
marked differences	56305
the response of host astrocytes	56327
the response	56327
host astrocytes	56343
the different cell types transplanted	56362
the different cell types	56362
Transplants of OECs and SCs	56401
Transplants	56401
OECs and SCs	56416
the least glial hypertrophy	56438
these two purified populations of glial cells	56482
these two purified populations	56482
glial cells	56516
a very different result	56559
transplants containing fibroblast-like cells -LRB- PNFBs , SFs and olfactory bulb fibroblast-like cells -RRB-	56596
transplants	56596
fibroblast-like cells -LRB- PNFBs , SFs and olfactory bulb fibroblast-like cells -RRB-	56619
fibroblast-like cells	56619
PNFBs , SFs and olfactory bulb fibroblast-like cells	56642
PNFBs	56642
SFs	56649
olfactory bulb fibroblast-like cells	56657
Transplants of these cell types	56696
Transplants	56696
these cell types	56711
a more extensive glial hypertrophy	56749
the injury site	56797
a length of the cord double that seen for pure glial cell transplants	56827
a length	56827
the cord double that seen for pure glial cell transplants	56839
the cord double	56839
pure glial cell transplants	56869
addition	56901
injections of the cells into the normal cord	56911
injections	56911
the cells into the normal cord	56925
the cells	56925
the normal cord	56940
a reaction in the host tissue that extended well beyond the bolus of transplanted cells	56964
a reaction	56964
the host tissue	56978
the bolus of transplanted cells	57020
the bolus	57020
transplanted cells	57033
GFAP and nestin IR	57053
a radial pattern in host tissue	57107
a radial pattern	57107
host tissue	57127
the transplanted cells that was not seen for pure glial cell transplants	57151
the transplanted cells	57151
pure glial cell transplants	57196
olfactory bulb fibroblast-like cells to an equal quantity of OECs	57233
olfactory bulb fibroblast-like cells	57233
an equal quantity of OECs	57273
an equal quantity	57273
OECs	57294
the astrocytic hypertrophy	57309
the extent of the glial scar	57344
the extent	57344
the glial scar	57358
that for OECs and olfactory bulb fibroblast-like cells	57398
that	57398
OECs and olfactory bulb fibroblast-like cells	57407
OECs	57407
olfactory bulb fibroblast-like cells	57416
The most extensive scarring of all	57454
The most extensive scarring	57454
all	57485
transplants of the heterogeneous cell mixture obtained from the olfactory mucosa	57524
transplants	57524
the heterogeneous cell mixture obtained from the olfactory mucosa	57539
the heterogeneous cell mixture	57539
the olfactory mucosa	57584
The glial scar	57606
following injury to the CNS	57630
following injury	57630
the CNS	57650
complex cellular and molecular mechanisms	57667
the current view	57713
it	57738
the response	57786
injury	57802
the one hand	57813
it	57827
the glia limitans	57860
the barrier	57889
the CNS	57908
the injured region	57931
the other hand	57954
this wound healing response	57970
a chemical and physical barrier	58011
axonal regeneration	58046
this aspect of structural repair -LRB- Faulkner et al. , 2004 ; Sofroniew and Vinters , 2010 -RRB-	58076
this aspect	58076
structural repair -LRB- Faulkner et al. , 2004 ; Sofroniew and Vinters , 2010 -RRB-	58091
structural repair	58091
Faulkner	58110
et al. , 2004 ; Sofroniew and Vinters , 2010	58119
et al.	58119
2004 ; Sofroniew and Vinters	58127
2004	58127
Sofroniew and Vinters	58133
2010	58156
The transplants of fibroblast-like and OM cells	58163
The transplants	58163
fibroblast-like and OM cells	58182
a response	58227
astrocytes	58241
the lesion boundary	58264
the host spinal cord	58293
we	58325
functional tests on transplanted animals	58346
functional tests	58346
transplanted animals	58366
we	58387
the exacerbation of the scarring response induced by these cells to be an undesirable property , incompatible with strategies to treat spinal cord injury that seek to reconstruct the damaged injury site	58399
the exacerbation	58399
the scarring response induced by these cells to be an undesirable property , incompatible with strategies to treat spinal cord injury that seek to reconstruct the damaged injury site	58419
the scarring response	58419
these cells	58452
an undesirable property , incompatible with strategies to treat spinal cord injury that seek to reconstruct the damaged injury site	58470
an undesirable property	58470
strategies	58513
spinal cord injury that seek to reconstruct the damaged injury site	58533
spinal cord injury	58533
the damaged injury site	58577
It	58602
differences in host/transplant interactions seen for different cells types	58622
differences	58622
host/transplant interactions seen for different cells types	58637
host/transplant interactions	58637
different cells types	58675
implications for the penetration of regenerating axons into the graft in our study	58702
implications	58702
the penetration of regenerating axons into the graft in our study	58719
the penetration	58719
axons	58751
the graft in our study	58762
the graft	58762
our study	58775
the transplants	58793
axons	58836
the opportunity to enter the transplant before the glial reaction fully developed	58856
the transplant	58881
the glial reaction	58903
It	58939
the greater reactivity	58967
it	58996
axons	59031
the graft	59046
This	59057
the current study	59089
tract-tracing	59115
none of the transplants	59141
none	59141
the transplants	59149
regeneration , that is , regeneration beyond the transplant	59184
regeneration	59184
regeneration beyond the transplant	59207
regeneration	59207
the transplant	59227
this lack of bridging regeneration both the relative ability of the cell	59251
this lack	59251
regeneration both the relative ability of the cell	59273
regeneration	59273
the relative ability of the cell	59291
the relative ability	59291
the cell	59315
transplants to support regeneration and their ability to integrate with the host environment	59324
regeneration and their ability	59347
regeneration	59347
their ability	59364
the host environment	59396
significance	59428
future studies using combined treatments designed to allow such regeneration to occur	59445
future studies	59445
combined treatments designed to allow such regeneration to occur	59466
combined treatments	59466
such regeneration	59504
there	59541
little difference in the extent of the glial scarring associated with OEC and SC transplants in the wire knife injury at the macroscopic level	59551
little difference	59551
the extent of the glial scarring associated with OEC and SC transplants in the wire knife injury at the macroscopic level	59572
the extent	59572
the glial scarring associated with OEC and SC transplants in the wire knife injury at the macroscopic level	59586
the glial scarring	59586
OEC and SC transplants in the wire knife injury	59621
OEC and SC transplants	59621
the wire knife injury	59647
the macroscopic level	59672
there	59695
well-established differences in the interaction between these cells and host astrocytes	59705
well-established differences	59705
the interaction between these cells and host astrocytes	59737
the interaction	59737
these cells and host astrocytes	59761
the cellular and molecular levels	59796
In vitro , OECs	59831
In vitro	59831
OECs	59841
less of a reactive response in astrocytes and less chondroitin sulfate proteoglycan expression	59853
a reactive response in astrocytes and less chondroitin sulfate	59861
a reactive response	59861
astrocytes and less chondroitin sulfate	59884
astrocytes	59884
less chondroitin sulfate	59899
SCs	59953
addition	59961
OECs	59977
astrocytes in a co-culture	60001
astrocytes	60001
a co-culture	60015
SCs	60029
a distinct boundary -LRB- Lakatos et al. , 2000 , 2003 ; Santos-Silva et al. , 2007 -RRB-	60046
a distinct boundary	60046
Lakatos	60067
et al. , 2000 , 2003 ; Santos-Silva et al. , 2007	60075
et al.	60075
2000 , 2003 ; Santos-Silva et al.	60083
2000 , 2003	60083
2000	60083
2003	60089
Santos-Silva et al.	60095
Santos-Silva	60095
et al.	60108
2007	60116
This	60123
the current study	60143
other spinal cord injury models	60199
transplants of OECs and SCs	60237
transplants	60237
OECs and SCs	60252
a dorsal column crush model	60280
the SC/host interface	60315
a continuous astrocytic boundary	60357
the OEC/host interface	60391
openings	60424
the astrocyte layer -LRB- Andrews and Stelzner , 2007 -RRB-	60436
the astrocyte layer	60436
Andrews and Stelzner	60457
2007	60479
addition	60489
a moderate contusion injury model	60522
OECs	60557
less astrocytosis and lower levels of chondroitin sulfate proteoglycans	60571
less astrocytosis	60571
lower levels of chondroitin sulfate proteoglycans	60593
lower levels	60593
chondroitin sulfate proteoglycans	60609
SCs -LRB- Takami et al. , 2002 -RRB-	60648
SCs	60648
Takami	60653
et al. , 2002	60660
et al.	60660
2002	60668
These actions	60675
important implications for the repair potential of OECs -LRB- Raisman and Li , 2007 -RRB- suggesting some possible advantages over SCs	60698
important implications	60698
the repair potential of OECs -LRB- Raisman and Li , 2007 -RRB- suggesting some possible advantages over SCs	60725
the repair potential	60725
OECs -LRB- Raisman and Li , 2007 -RRB- suggesting some possible advantages over SCs	60749
OECs -LRB- Raisman and Li , 2007 -RRB-	60749
OECs	60749
Raisman and Li , 2007	60755
Raisman	60755
Li , 2007	60767
Li	60767
2007	60771
some possible advantages over SCs	60788
some possible advantages	60788
SCs	60818
Implications for Clinical Translation of Cell Transplantation	60823
Implications	60823
Clinical Translation of Cell Transplantation	60840
Clinical Translation	60840
Cell Transplantation	60864
Our results	60885
pure populations of glial cells , but also a more diverse range of differentiated cells types , including fibroblast-like cells not generally considered	60907
pure populations	60907
glial cells , but also a more diverse range of differentiated cells types , including fibroblast-like cells not generally considered	60927
glial cells	60927
a more diverse range of differentiated cells types , including fibroblast-like cells not generally considered	60949
a more diverse range	60949
cells types	60988
fibroblast-like cells not generally considered	61011
fibroblast-like cells	61011
unique regeneration promoting properties	61066
unique regeneration	61066
properties	61096
significant regeneration of axons	61120
significant regeneration	61120
axons	61148
transplantation	61160
dorsal column lesions	61181
none of the cell types	61213
none	61213
the cell types	61221
significant long distance axonal regeneration	61245
the emergent view	61303
cell transplants	61326
one element of a combined strategy	61364
one element	61364
a combined strategy	61379
axonal regeneration -LRB- Murray and Fischer , 2001 ; Bunge , 2008 ; Kadoya et al. , 2009 ; Gros et al. , 2010 -RRB-	61413
axonal regeneration	61413
Murray and Fischer , 2001 ; Bunge , 2008 ; Kadoya et al. , 2009 ; Gros et al. , 2010	61434
Murray and Fischer	61434
2001 ; Bunge , 2008 ; Kadoya et al. , 2009 ; Gros et al.	61454
2001	61454
Bunge , 2008 ; Kadoya et al. , 2009 ; Gros et al.	61460
Bunge , 2008	61460
Bunge	61460
2008	61467
Kadoya et al. , 2009	61473
Kadoya	61473
et al. , 2009	61480
et al.	61480
2009	61488
Gros et al.	61494
Gros	61494
et al.	61499
2010	61507
The study	61514
transplants of fibroblast-like cells , or transplants containing fibroblast-like cells ,	61548
transplants of fibroblast-like cells	61548
transplants	61548
fibroblast-like cells	61563
transplants containing fibroblast-like cells	61589
transplants	61589
fibroblast-like cells	61612
a more marked host cell response than purified glial cell populations	61643
a more marked host cell response	61643
glial cell populations	61690
candidates for cell mediated repair	61728
candidates	61728
cell mediated repair	61743
an environment permissive for axonal regeneration	61777
an environment permissive	61777
axonal regeneration	61807
our study	61827
it	61851
account of how readily the cells integrate with the host spinal cord	61885
account	61885
the cells	61908
the host spinal cord	61933
This	61955
important implications for the choice of cells for clinical use	61964
important implications	61964
the choice of cells for clinical use	61991
the choice	61991
cells for clinical use	62005
cells	62005
clinical use	62015
some clinical programmes	62050
olfactory tissues	62085
e.g. olfactory mucosa -LRB- Lima et al. , 2006 ; Iwatsuki et al. , 2008 -RRB- or fetal tissue -LRB- Huang et al. , 2006 ; Liu et al. , 2010 -RRB- , rather than purified cell cultures	62103
e.g. olfactory mucosa -LRB- Lima et al. , 2006 ; Iwatsuki et al. , 2008 -RRB- or fetal tissue -LRB- Huang et al. , 2006 ; Liu et al. , 2010 -RRB- , rather than purified	62103
e.g.	62103
olfactory mucosa -LRB- Lima et al. , 2006 ; Iwatsuki et al. , 2008 -RRB- or fetal tissue -LRB- Huang et al. , 2006 ; Liu et al. , 2010 -RRB-	62108
olfactory mucosa -LRB- Lima et al. , 2006 ; Iwatsuki et al. , 2008 -RRB-	62108
olfactory mucosa	62108
Lima	62126
et al. , 2006 ; Iwatsuki et al. , 2008	62131
et al.	62131
2006 ; Iwatsuki et al.	62139
2006	62139
Iwatsuki et al.	62145
Iwatsuki	62145
et al.	62154
2008	62162
fetal tissue -LRB- Huang et al. , 2006 ; Liu et al. , 2010 -RRB-	62171
fetal tissue	62171
Huang	62185
et al. , 2006 ; Liu et al. , 2010	62191
et al.	62191
2006 ; Liu et al.	62199
2006	62199
Liu et al.	62205
Liu	62205
et al.	62209
2010	62217
cell cultures	62245
it	62264
the greater reactivity of the diverse cells types within these tissues	62284
the greater reactivity	62284
the diverse cells types within these tissues	62310
the diverse cells types	62310
these tissues	62341
summary	62386
our results	62395
the cells compared here	62424
the cells	62424
pure preparations of glial cells -LRB- OECs and SCs -RRB-	62449
pure preparations of glial cells	62449
pure preparations	62449
glial cells	62470
OECs and SCs	62483
OECs	62483
SCs	62492
an optimal combination of desirable properties	62505
an optimal combination	62505
desirable properties	62531
maximal support for axonal regeneration	62563
maximal support	62563
axonal regeneration	62583
a minimal glial reaction	62617
the transplant site	62649
This information	62670
the choice of cells for use	62712
the choice	62712
cells for use	62726
cells	62726
use	62736
future combinatorial therapies for spinal cord injury	62743
future combinatorial therapies	62743
spinal cord injury	62778
indeed purified cells	62801
transplant	62841
repair	62861
this in turn	62873
this	62873
turn	62881
implications for the sourcing of cells and quality control of the culture process	62890
implications	62890
the sourcing of cells and quality control of the culture process	62907
the sourcing	62907
cells and quality control	62923
the culture process	62952
a considerable volume of cells	62978
a considerable volume	62978
cells	63003
a human spinal cord injury	63034
It	63062
some of the stem cell and stem	63106
some	63106
the stem cell and stem	63114
cell-derived cell types currently being investigated for use in spinal cord injury	63137
cell-derived cell types	63137
use in spinal cord injury	63194
use	63194
spinal cord injury	63201
their regeneration supporting properties	63238
their regeneration	63238
properties	63268
cells	63305
their interaction with the host spinal cord	63336
their interaction	63336
the host spinal cord	63359
that of glial cells or that of fibroblast-like cells	63390
that of glial cells	63390
that	63390
glial cells	63398
that of fibroblast-like cells	63413
that	63413
fibroblast-like cells	63421
